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ABSTRACT 
The development of nanomedicine is based primarily on the development of smart and 
multifunctional nanomaterials that can serve under the different clusters including drug delivery 
systems, diagnostics, and regenerative medicine. Recently, carbon nanotubes (CNTs) have received 
enormous attention due to their extraordinary properties. CNTs have a wide range of applications 
and are used in a variety of products thus exposure to CNTs has become unavoidable, which may 
prompt an inflammatory response. The present Thesis is focused on studying CNTs especially 
addressing the key challenges highlighted by the Food and Drug Administration and the Alliance 
for Nano-Health, including imaging, biodistribution, interaction with biological environment, and 
predictive modeling. 
For imaging in order to evaluate biodistribution we were able, for the first time, to use thermostable 
Luciferase from Luciola cruciate (LcL) as a qualitative imaging modality. LcL offers an alternative 
approach for following the biodistribution of CNTs over time. The biodistribution profile of CNTs 
was found to be similar to the majority of nanoparticles, falling in the same size criteria, and 
predominantly accumulate in the liver. This raised the question whether CNTs could interfere with 
the liver functionality explicitly the metabolizing activity of drugs and other xenobiotics by phase I 
metabolizing enzymes CYP450.  
We therefore studied the ability of single wall carbon nanotubes (oxSWNTs) on inhibiting 
enzymatic capacity of CYP3A4. We found that oxSWNTs inhibit mediated conversion of 
testosterone (as a model compound), to its major metabolite 6β-hydroxy testosterone in a dose 
dependent manner. When oxSWNTs is pre-coated with bovine serum albumin, the enzymatic 
activity of CYP3A4 was restored. Also, the covalent functionalization of oxSWNTs with 
polyethylene glycol (PEG) has shown to have no influence on the enzymatic activity of CYP3A4. 
Further understanding of the molecular interactions was obtained by computational modeling and 
simulations (MD).   MD simulations revealed that the inhibition of CYP3A4 catalytic activity is 
mainly due to blocking of the exit channel for substrate/products through a complex binding 
mechanism. CYP3A4 is a well-recognized isozyme accountable for the metabolization of various 
endogenous and exogenous xenobiotics by means of the monooxygenase cycle.  
In the Thesis, we also studied the degradation of pristine and oxidized SWNTs (p-SWNTs, 
oxSWNTs) by CYP3A4, by Raman spectroscopy. We found that both p-SWNTs and oxSWNTs 
were degraded as evidenced by the increase of D-band, which corresponds to the increase of the 
structural defects. Surprisingly, CYP3A4 bactosomes were more proficient in degrading p-SWNTs 
more than oxSWNTs under similar incubation conditions. MD simulations suggested that CYP3A4 
has a higher affinity for p-SWNTs (minimal MolDock Score of −186.34 kcal/mol) compared to 
oxSWNTs which bind in a weaker manner (MolDock Score = −111.47 kcal/mol).  
Pulmonary accumulation of CNTs has shown to be critical. We therefore studied the biodegradation 
of oxSWNTs by Lactoperoxidase (LPO), a secreted peroxidase enzyme present in the mucus of the 
airways. We also investigated whether pulmonary surfactants can play a role in the biodegradation 
of oxSWNTs. Biodegradation was monitored using Raman spectroscopy, scanning electron 
microscopy, and UV–Vis–NIR spectroscopy. The biodegradation of oxSWNTs was not impeded by 
the formation of protein corona formed in the presence of lung surfactant (Curosurf®). Moreover, 
cell-free digestion of oxSWNTs was observed ex vivo in murine bronchoalveolar lavage fluid in the 
presence of peroxidase cofactors.  
Since CNTs is studied as a theranostic agent, we therefore studied the biodegradation of PEGylated 
oxSWNTs. PEG is acknowledged as the gold standard for extending blood circulation times for 
many biological molecules. OxSWNTs functionalized with PEG of different molecular weight 
(MW) were incubated with myeloperoxidase (MPO). Biodegradation was noted only for oxSWNTs 
chemically functionalized with PEG. There was no sign of degradation of oxSWNTs with 
physically adsorbed PEG, nor for p-SWNTs. The extent of oxSWNT biodegradation by MPO was 
inversely proportional to the molecular weight of the PEG chains. Ex vivo biodegradation using 
isolated primary human neutrophils revealed that both chemically and physically PEGylated 
oxSWNTs undergo biodegradation independently of the PEG chain MW. These ex vivo findings 
suggest that, in a cell system, a combined process of stripping and biodegradation of PEGylated 
oxSWNTs might occur. 
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1 INTRODUCTION 
1.1 NANOPARTICLES AND NANOTECHNOLOGY 
Nanoparticles are the basic fundamental building units of nanomaterials. The physical, 
chemical and biological properties of the nanostructured materials differ substantially from 
their micron and bulk counterparts [1]. The definition of a nanoparticle varies according to 
specific application. Various organizations for standardization have issued a strict definition 
[2]. Table 1.1 reviews the different size definitions of nanoparticles. In 2011, the European 
commission endorsed a broader yet more nominal definition stating that “a natural, 
incidental or manufactured material containing particles in an unbound state or as 
agglomerate or as an aggregate and where for 50% or more of the particles in the number 
size distribution, one or more external dimensions in the size range 1nm-100nm”[3].  
International organizations for standardization Definition 
 Federal institute for occupational safety and health  
(BAuA) 
All the dimensions or diameters are in the nanoscale range 
 Scientific Committee on Consumer Products 
(SCCP) 
At least one dimension is in the nanoscale range. 
 National Institute of Occupational Safety and 
Health (NIOSH) 
A particle with diameter between 1 and 100 nm, or a fiber 
spanning the range 1–100 nm 
 International Organization for Standardization 
(ISO) 
A material confined in 1 or more  dimensions at the nanoscale 
(ca. 1-100nm) 
 British Standards Institution (BSI) All the fields or diameters are in the nanoscale range 
Table 1.1 Definitions of nanoparticles by various organizations 
Nanoparticles have an astonishingly long antiquity; the earliest evidence belongs to the 4
th
 
century so called Lycurgus cup [4]. The extraordinary cup, held by the British museum, 
contains gold and silver nanoparticles that amend the color of the glass depending on the 
position of the observer due to the quantum size effect of the nanoparticles [5]. Another 
amazing discovery was the existence of gold nanoparticles in the stained glass present in the 
medieval European churches purifying the air and also adding a glimpse of luster to the 
decoration [6, 7]. Moreover, nearly a decade ago researchers reported that ancient Egyptians 
utilized lead sulfide nanocrystals as a hair dyeing recipe [8]. With numerous references to 
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nanoparticle application from ancient times, there is no uncertainty that nanoscience was 
pioneered centuries ago yet the lack of technology (i.e. electron microscopy) for visualization 
of such small entities made it impossible to further develop this marvelous technology.  
With the invention of transmission electron microscopy in the early 19
th
 century [9], an 
innovative era was inaugurated, the era of “Nanotechnology“. Nanotechnology emerged as an 
invincible giant changing the course of science in all fields utilizing nanoparticles as building 
components. Nanotechnology contributed significantly to interdisciplinary fields including 
medicine, materials, chemical catalysis, and micro-wiring. Given the broad-reaching 
prospective of nanotechnology, the world acquired a commensurate action in terms of global 
research and development. It is estimated that the world governments, private sectors and 
corporates have financed nanotechnology applications with approximately € 0.23 trillion by 
2015 [10]. 
1.2 DEVELOPMENT OF NANOMEDICINE 
The idea was originally inspired by Paul Ehrlich, who perceived that the creation of a therapy 
called “Zauberkugeln” (Magic Bullets) would alter the course of medical treatment; being a 
great immunologist he had antibodies in mind [11]. The concept was revolutionized in the 
1950’s to include therapeutic loaded nanoparticles as a potential targeting moiety. Although it 
seems like a simple approach, it required the adaptation of a new thinking and research 
methodology to realize the full potential of nanoparticles. 
 In 2005 the European commission initialized nanomedicine strategic research, which was 
defined as “the application of Nanotechnology to Health. It exploits the improved and often 
novel physical, chemical, and biological properties of materials at the nanometric scale. 
NanoMedicine has potential impact on the prevention, early and reliable diagnosis and 
treatment of diseases” [12]. The field was divided into three main clusters 1) targeted drug 
delivery, 2) regenerative medicine, 3) diagnosis [13, 14].  To aid the rapid development in 
any of these biological clusters, multifunctional nanomaterials were demanded.   
1.3 MULTIFUNCTIONAL NANOMATERIALS  
Multifunctional nanomaterials known also as theranostic agents are a distinctive breed of 
nanoparticles/materials that perform multiple tasks simultaneously, such as biological 
imaging, biosensing, drug delivery, targeting special organelles [15], controlled release and 
dual therapeutic effect. In addition, the nano magnitude of these carriers offers a high 
surface area-to-volume ratio, permitting high loading capacity of therapeutic drugs. 
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Theranostic agents can be physically, chemically and morphologically tailored to fulfill the 
requirements of a predefined application [16]. 
Several classes of multifunctional nano-carriers have been developed;  they can be 
categorized according to their dimensions as 0D (quantum dots, nanoparticles, 
nanospheres), 1D (nanorods, nanotubes, nanowires), 2D (nanofilms, nanosheets), or 3D 
(bulk materials with nanoscale structure, nanocomposites and mesoporous materials) [17]. 
The chemical nature of the nanomaterials can be also used as a classification category. 
Figure 1 shows the arsenal of organic, inorganic and hybrid multifunction nanosystems. 
The most extensively investigated class is the polymeric nanoparticles, predominantly the 
liposomes subcategory. Some of these theranostic agents have  been approved by regulatory 
authorities and translated to clinical use, while others are still in clinical trials [18]. Some of 
the theranostic agents that have successfully entered the market are Doxil, Myocet, 
Abraxane, Endorem, Resovist and ThermoDox. 
With basic nanoparticle synthesis becoming a routine and driven by the growing medical 
need for novel tools, carbon based nanomaterials emerged as a lucrative nanomaterial as 
they offer a hybrid advantage compared to other nano-carrier classes.  
 
Figure 1. The arsenal of organic, inorganic and hybrid multifunctional drug delivery 
carriers. Adapted from ref. [19] with permission of The Royal Society of Chemistry. 
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Figure 2. Carbon nanotubes of different structural 
configurations.  
2 CARBON NANOTUBES 
 
Carbon nanotubes (CNTs) are seamless cylinders of graphene sheets.  The ends of the 
CNTs are concealed by a hemispherical buckyball [20].  Ideally, pristine CNTs (p-CNTs) 
have all carbons bonded in a hexagonal lattice (sp2 conjugated lattice) [21, 22]. 
Nevertheless, in reality, pristine mass produced CNTs contain topological defects in their 
atomic structure (octagon, pentagon, heptagon) [23-25], rehybridization defects depending 
on the chirality [26, 27], and incomplete bonding [28]. Depending  on the number of the 
graphene sheet layers the CNTs are composed of, CNTs are divided in to single wall 
(SWNTs) [29], double wall (DWNTs) [30-33], triple wall (TWNTs) [34-37] and multiwall 
(MWNTs) [38]. Concurrently, the diameter varies from 3 Å for SWNTs [39, 40] up to 200 
nm for MWNTs [41].   
The commencement of widespread CNT research in the 1990s as an essential contributor to 
nanotechnology advancement, as well as to fulfill nanotube structure-property relations, 
demanded the development of controlled mass production of CNTs with desired properties 
and structure.  
2.1 CNTS SYNTHESIS CONCEPT 
The building of CNTs requires exquisite control at the atomic level. With such precise atomic 
structural arrangement, infinite possible chiralities (the chiral angle between the CNT axis 
and hexagons) can be constructed. There are 3 defined structures known as armchair, zigzag 
and chiral  [42]. Regardless of the 
simple atomic bonding 
configuration and chemical 
composition of CNTs, the different 
chiralities play a vital role in their 
biological [43], chemical [44], and 
physical properties [45-47]. 
Dependent on the helicity of the 
structure, SWNTs can be either 
metals or semiconductors [48-51].  
Understanding the nucleation and 
controlling the growth mechanism to achieve desirable characteristics is a key goal for 
material scientists [52-54]. 
  11 
Several techniques have been developed to fabricate CNTs. Chemical vapor deposition 
(CVD), laser ablation, and arc discharge are the most established methodologies for 
successful growth based on gas phase processes [53, 55]. Other methods are the electrolysis 
[56, 57] and sonochemical [58-60]. Among these approaches,  CVD is the cheapest, most 
controllable and highly productive method offering the best control of nanotube diameter, 
length, alignment and purity [61, 62].   
2.2 FUNCTIONALIZATION OF CARBON NANOTUBES 
Flawless p-CNTs formed of defect free hexagonally arranged aromatic rings are chemically 
inert [63]. p-CNTs have a pronounced tendency to agglomerate and are known to be aqua 
insoluble or have limited solubility in any known solvent. To facilitate the processing and 
transformation of CNTs to the application phase, functionalization strategies have been 
introduced. Functionalization stands for creating active functional moieties on the surface of 
the CNTs. Functionalization categories includes defect-site functionalization, covalent 
functionalization, and non-covalent functionalization.  
Figure 3.  Different 
functionalization 
strategies for carbon 
nanotubes A) defect-
site functionalization, 
B) covalent 
functionalization, C) 
non-covalent 
exohedral 
functionalization with 
surfactants, D) non-
covalent exohedral 
functionalization with 
polymers, and E) 
endohedral 
functionalization. 
Reproduced from ref.  
[64] with permission 
from John Wiley and 
Sons. 
 
 
2.2.1 Defect site functionalization 
The most common functionalization approach is the “oxidative purification” of CNTs, which 
can be achieved through a liquid phase or gas phase [65]. The most utilized oxidative agents 
are nitric acid, sulfuric acid, hydrogen peroxide, ozone, air or a combination of these phases 
[65, 66].  Oxidative treatment introduces oxygen bearing groups at the side walls and the end 
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of the CNTs such as carboxylic, phenolic and lactone. The ratio of oxygen moieties can also 
be controlled by adjusting the acid/CNT ratios [67-69]. This method also serves as a 
purification method eliminating the remaining catalyst used for the CNT growth and the 
amorphous carbon. In addition, oxidative protocols lead to the shortening/cutting of the raw 
CNT which is vital for some biomedical applications maneuvering through toxicity and 
biocompatibility [70-72]. The cutting can even result in ultra-short CNTs of ca. 5nm [73, 74].  
On the other hand, it is a harsh treatment that leads to the loss of the electronic properties of 
the CNTs [75, 76].   
Oxidative treatments are typically used as a pre-modification since the grafted functional 
oxygen groups can be exploited to introduce further chemical transformations or entities. 
Carboxamides can be derived from carboxylic acid groups facilitating decoration with aryl 
amines, aliphatic amines, and amino acid derivatives [65, 77]. Thiolation is another further 
transformation that carboxylic groups and hydroxyl groups can adapt [78, 79]. It is also 
common to use the oxygen functional groups to form ester bonds directly with 
macromolecules of interest. 
2.2.2 Covalent functionalization of CNTs 
The chemical reactivity of strained quasi-1D cylindrical aromatic CNTs to covalent addition 
reactions arises from its geometric topology. Local strain on the sidewalls of CNTs is 
prompted due to the wall curvature promoting two main factors, 1) π-orbital misalignment 
between adjacent carbons, and 2) pyramidalization at the carbon atom [80]. From a chemical 
point of view, it is essential to note that the chemistry of the sidewalls is completely different 
from the cap chemistry. The caps are composed of a semispherical fullerene with almost a 
perfect π orbital alignment and the high reactivity arises from the pyramidalization at the 
carbon atoms [81, 82]. This is not the case with the side walls, where the π orbital 
misalignment makes a greater contribution to the chemical reactivity [65, 83] .  
Addition reactions are by far the most common organic reactions utilized for covalent 
functionalization. The chemical nature of CNTs comprised of carbon-carbon double bonds 
(alkenes), or with triple bonds (alkynes) in defected sites facilitates the utilization of addition 
reactions. Several modes for addition reactions exist including halogenation, chlorination, 
addition of radicals, addition of nucleophilic carbenes, as well as addition of carbenes or 
nitrenes [84-87]. It is worth mentioning that there is no method to date that can synthesize a 
defined nature of chiral tubes, and a discrepancy in reactivity of current CNTs depending on 
their diameters is expected; a smaller diameter CNT is anticipated to be more reactive [88]. 
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Moreover, it is challenging to gain control over the regio-selectivity of such addition 
reactions [88].  
2.2.3 Non-covalent functionalization of CNTs 
Non-covalent functionalization is acknowledged owing to the noninvasive/nondestructive 
treatment. This mode of converting the hydrophobic characteristic of the CNTs to more 
hydrophilic ones preserves the chemical and structural nature of the pristine CNTs 
eradicating any altering in the optical and physicochemical properties. Non-covalent 
functionalization is a very attractive surface treatment for various applications that demand 
certain optical or electronic properties [65]. Non-covalent approaches utilize small aromatic 
molecules, macromolecules (surfactants [89-91] and synthetic or natural polymers [92-94]), 
or highly charged nanoparticles [95, 96] to adsorb on the surface of the CNT structures to 
achieve a stable suspension. The physical attachment/anchoring of such molecules is 
conceivable due to the π-π interactions [97-100], CH–π interactions [101, 102], OH-π 
interactions [103, 104], cation-π interactions [105-107] , and hydrophobic interactions [108-
111]. 
 The efficiency in obtaining high concentrations of CNT suspension is vastly sensitive to the 
dispersion parameters, like the initial concentrations of CNTs and the chosen dispersant, the 
composition [112, 113], diameter and the chirality [114] of the initial pristine material, 
sonication power and sonication time [115] interval. Environmental factors like pH [116] and 
temperature [117] also affect the quality of the suspension.  
From a biological rationale, CNT surface modification is crucial to potential in in vivo 
applications. Different surface functional groups manipulate the surface charge and the 
surface density, and thus have different biological distribution, response and pharmacology.  
2.3 CARBON NANOTUBES IN BIOLOGY AND MEDICINE 
2.3.1 Biodistribution profile of pristine and functionalized CNTs 
The pharmacokinetics and biodistribution of CNTs rely intensively on the administration 
route and physicochemical properties such as size, aggregation, shape, surface modification, 
and chemical compositions. With the pronounced promise CNTs exhibit, biodistribution 
becomes an imperative question that needs to be examined after systematic administration in 
an animal model. Various tracking and imaging methods have been applied for determining 
the biodistribution.  
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2.3.1.1 Radionuclide and fluorescent tagging-based imaging 
McDevitt et al. [118] investigated the biodistribution of i.v. and i.p. administered radiolabeled 
(
86
Y-DOTA or 
111
ln-DOTA) SWNTs in mice. These SWNTs were covalently functionalized 
by 1,3-dipolar cycloaddition to bear amine groups. The PET/CT study showed that the major 
accumulation organs after 24 hours for both i.p. and i.v. administration were the liver, kidney 
and spleen and (to a much lesser extent) the bone. Controversially, Singh et al. [119]  
reported that radiolabeled (
111
In-DTPA) SWNTs  and MWNTs functionalized in the same 
manner showed rapid urinal clearance of the SWNT constructs, with the majority (>95%) 
cleared out within 3 hours. No uptake in reticuloendothelial organs such as the liver and 
spleen was observed. Both studies provide clear evidence that SWNTs constructed with such 
functionalization act like small molecules. They are most likely cleared via active secretion 
into the tubular lumen and via longitudinal filtration through the renal glomeruli evidenced by 
the accumulation of SWNT constructs in the renal cortex region where filtration takes place  
[118].   Similar observations were reported by Gao et al. [120] investigating the 
biodistribution of i.p. injected  
99m
Tc-labeled acid oxidized MWNTs amended amine terminal 
through acyl chloride mediated reaction.  
Liu et al. [121] studied the biodistribution of (
64
Cu-DOTA) SWNTs surface modified through 
anchoring PL–PEG-NH2 by hydrophobic interactions. The results revealed that SWNT 
constructs were prominently taken up in the liver and spleen after 24 hours (i.p. injection). 
More remarkable, Liu et al. [121] demonstrated that the high molecular weight PEG reduced 
the tendency of SWNT constructs to undergo RES uptake. RES uptake occurs through 
identification of phagocytes to the antibody that tags the SWNTs in the plasma. The 
minimization of antibody tagging enhanced the blood circulation time of the SWNT 
constructs [122]. These results demonstrate that both kinds of functionalized SWNTs follow 
a similar pattern for RES uptake compared to that of other nanomaterials with a size of ca.10-
100 nm [123]. A similar pattern of RES accumulation was reported for radio tracer labelled 
MWNTs [124]. 
Another traditional modality to track the biodistribution of SWNTs is fluorescent tags. Kang 
et al. [125] studied the biodistribution of fluorescent tagged short SWNTs non-covalently 
functionalized by a chitosan. 3 hours after i.v. injection, the liver was found to have the 
highest share of accumulation followed by the spleen and kidney. 
The radio-labeled and fluorescent tagging method is a convenient way that allows imaging of 
molecular and cellular events in the living system, offering qualitative and quantitative data. 
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Radio tracer offers a detection level down to picomolar. However, extreme caution should be 
taken to evaluate the results as excess free radioisotopes and tags may lead to 
misinterpretation. Also, radionuclide can be gradually released from the chelating complex, 
leading to deceptive results. Thus it might not be the ideal strategy for imaging over an 
extended period of time. To overcome the traditional tracking drawbacks, researchers have 
investigated the in vivo accumulation of functionalized SWNTs relying on their intrinsic 
properties. 
2.3.1.2 SWNTs intrinsic property-based imaging 
SWNTs exhibit distinct physical properties, which makes them more appealing for medical 
applications. Imaging SWNTs with no surface or minimum surface modification gives a 
vibrant proof regarding the actual biodistribution. Adding an external moiety to facilitate 
imaging induces chemical alterations to the CNTs and may lead to misleading results. 
Liu et al. [126] utilized the unusual electronic and phonon properties as a direct long term 
detection of SWNT surface functionalized by PL–PEG. Another advantage is that Raman 
signals are stable against photobleaching. The robust Raman scattering showed superior 
accumulation of SWNT constructs in the liver, spleen, and intestine lysates 3 days post i.v. 
administration. Raman spectroscopy offers high sensitivity permitting the following of 
SWNT constructs up for 100 days. The results showed that only small fraction of SWNTs 
below the renal excretion threshold (ca. 5.5 nm) can be passed as urine, proposing that 
excretion occurs mainly via the biliary pathway ending up in feces [126, 127].   
An intriguing study investigated the biodistribution of pristine SWNTs (p-SWNTs) 
synthesized to bare 13C as a building unit in the tube structure [128]. The results show 
distribution to the whole body with major accumulation mainly in the lungs, followed by 
the spleen and liver. Lung accumulation is predictable due to the long length of the SWNTs 
(ca. 2-3 µm). It is worth emphasizing that long term accumulation is very different for 
pristine tubes compared to functionalized ones. p-SWNTs  were not cleared  by either the 
biliary pathway or renal excretion and remained in a high concentration 28 days after i.p. 
injection [128]. Consistent results were demonstrated by Faraj et al. [129] who reported the 
biodistribution of purified and raw p-SWNTs in a rat model using 
3
He and 
1
H magnetic 
resonance imaging by means of the metal catalyst impurities. This study concluded that 
1
H 
MRI allowed detection of intravenously injected p-SWNTs, and that hyperpolarized 
3
He 
can be used for the investigation of CNT pulmonary biodistribution. 
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Another intrinsic property is that individual SWNTs have small band gaps on the order of 
~1 eV. The small band gaps permit monitoring through their NIR photoluminescence (900-
1600 nm) which has high optical transparency of biological tissue, least interference from 
biological media and inherently low auto-fluorescence from tissue. Cherukuri et al. [130] 
showed that copolymer Pluronic F108-coated SWNTs accumulate in the liver mainly after 
jugular vein administration. The limitation of imaging by means of NIR fluorescence is that 
it only permits short time tracing of semiconductor SWNTs that maintain its electronic 
integrity [131]. Moreover, preparation of p-SWNTs by surfactants or polymers affects the 
quantum efficiency; thus quantitative data is hard to obtain [132]. Another drawback is that 
quantitative data is difficult to obtain using NIR fluorescence technique [133].  
In summary, the different biodistribution studies of SWNTs functionalized by different 
methods show no organ specific affinity, which can be considered an advantage for the 
development of targeted complexes, because there is no distinctive tissue affinity to 
overcome. 
2.3.2 Carbon nanotubes as therapeutic delivery carriers 
2.3.2.1 Anti-cancer therapeutics delivery by CNTs 
Regardless of the numerous advancements in the field of cancer therapeutics, there are still 
many barriers to conventional administration. The major hurdles are tissue selectivity by 
the treatment, poor distribution of the drug among cells, limited solubility of the therapeutic 
molecule, high interstitial fluid pressure and target resistance to the therapeutic drug in 
multidrug resistant cancers [134-136].  
CNTs compared to other multifunctional nanocarriers possess many thrilling features that 
make them a potential candidate to overcoming the challenges of nanotechnology in cancer 
treatment. CNTs can cross the cellular membrane through multiple pathways: 1) energy 
dependent mechanisms, 2) energy independent mechanisms, or 3) direct translocation 
independent of method of functionalization of CNTs. Al-Jamal et al. [137] studied  both 
phagocytic and non-phagocytic cell  uptake of amine functionalized MWNTs by means of 
3D electron tomography, showing that cellular translocation occurs through membrane 
wrapping, direct membrane translocation, and within vesicular compartments. Kostarelos 
and colleagues [138-140] showed that even under endocytosis inhibiting conditions, other 
mechanisms contributed to the intracellular trafficking of SWNTs and MWNTs if surface 
modified with various strategies. In addition, the needle shape of CNTs facilitates drug 
molecule intercellular accumulation in cells via transmembrane penetration independent of 
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method of functionalization of CNTs [138, 141-143].  Cellular trafficking for SWNTs 
depends on the size of nanotube, cell type and degree of bundling [144]. Changing the 
cellular translocation for small molecules from passive diffusion to endocytic mechanism 
offers an alternative strategy to overcoming cell resistance to the chemotherapeutic agent. 
The oxidized SWNTs (oxSWNTs) loaded with doxorubicin boosted cellular uptake by 23 
fold and showed cytotoxicity against MDR P-glycoprotein overexpressing K562 human 
leukemia cells compared to free doxorubicin [145]. Another stimulating benefit of utilizing 
CNTs is their ability to accumulate at tumor sites through enhanced permeability and 
retention effect. The poorly formed structure of the lymphatic and tumor vasculature 
rapidly proliferating in tumor sites enable passive targeting of CNTs loaded with 
chemotherapeutic agents [146, 147]. Furthermore, CNTs offer a high aspect ratio and 
surface areas displaying a unique aptitude for multiple drugs with high loading capacity. 
2.3.2.2 Delivery of small-molecule drugs by CNTs 
Different categories of anticancer agents have been exploited as cargo for CNTs including 
topoisomerase I inhibitors (10-hydroxycamptothecin [148], camptothecin [149, 150], 
irinotecan [151]),  topoisomerase II inhibitors  (Etoposide [152]), Anthracyclines 
(doxorubicin [153-157],  epirubicin [158], daunorubicin [159], pirarubicin 
[160],   mitoxantrone [161]) platinum-based drugs (cisplatin [162, 163],   platinum (IV) 
prodrug  [164, 165],    antifolates  (Methotrexate [166, 167]), pyrimidine/purine antagonists 
(gemcitabine [168, 169], difluorodeoxycytidine [170]) and antimicrotubules (taxoid [171], 
docetaxel [172], paclitaxel [173, 174]). The aforementioned agents have been anchored to 
the side walls of the CNTs by means of covalent and non-covalent strategies as well as drug 
loading in the interior core of CNTs. The most studied agent is doxorubicin. Liu et al. [153] 
showed that exploiting the flat aromatic tetracyclic structure of doxorubicin facilitated 
strong π–π and hydrophobic interactions with the aromatic surfaces of CNTs reaching an 
ultrahigh loading capacity of around 400%. Furthermore, Wu et al. [175] showed that 
CNTs loaded with cytotoxic agents deliver comparable clinical efficacy at a 100-fold lower 
concentration compared to exogenous treatment. 
2.3.2.3 Generic-material delivery by CNTs 
Cancer gene therapy emerged as a promising method for treatment as an alternative approach 
to traditional chemotherapeutic agents [176]. Gene therapy is about the transfer of nucleic 
acids; most commonly plasmid siRNA, DNA, oligonucleotides and aptamers. Unlike small 
drug molecules that translocate to the cells by passive diffusion, biomacromolecules can 
hardly cross the cell membrane. These generic materials bypass the cellular barrier of 
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malignant cells by means of vectors. Genetic cargo facilitates cell death, immunomodulation 
or enforcing genetic corrections [177]. Nanocarriers have been introduced as vectors to 
overcome the hitches of viral vectors ranging from low transduction efficacy, low loading 
efficiency to possible host toxicity [177].  
CNTs offered a new opportunity and the fact that the chemical nature of the CNT walls can 
be functionalized endorsed them as ideal candidates for the delivery of nucleic acids [178]. 
Surface modified CNTs have demonstrated improvement in the transfection efficiency of 
plasmid DNA [143, 179-181], oligonucleotides [182, 183], siRNA [184-187], miRNA [188] 
and aptamers [189, 190]. It is worth mentioning that not only cationic or anionic surface 
modified CNTs were applicable to generic material delivery, but also siRNA loaded pristine 
SWNTs showed a promise in suppressing tumor growth and minimal toxicity [191].  Nucleic 
acids and aromatic nucleobases interact with CNT aromatic walls through π-π stacking 
interactions, permitting the generic material to form a wrap-like structure exposing the 
phosphate and sugar groups, thus improving the colloidal stability of CNTs [192]. DNA in 
particular has a curvature that matches the tube morphology, facilitating maximal binding 
affinity [193, 194]. 
2.3.3 Stimuli-responsive CNT-based drug delivery systems 
Environmentally sensitive drug delivery systems were introduced as smart structures that 
deploy the therapeutic cargo utilizing specific factors that are explicit in the unhealthy 
tissue. This concept was later realized to also serve in regulating the release behavior of 
single or multiple payloads in case of cocktail therapy. The controlled release prompts a 
higher synergistic effect with reduced side effects. With a prominent loading capacity of 
CNTs and to eliminate premature release in case of physical packing, the development of 
smart vesicles was further acknowledged.  
Several CNT-based smart systems have been designed to initiate and manipulate cargo 
release based on abnormalities in physiological/environmental conditions. Several studies 
designed CNT systems in response to either endogenous factors (pH [151-153, 195-199], 
enzymatic [148, 157, 166, 200], redox gradients [162, 164, 165, 171], and temperature 
[201]) or exogenous factors (electric [202-204], electromagnetic radiation [145, 205-207], 
magnetic [175] and ultrasound [170]). 
2.3.4 Active targeting of CNTs 
To further augment the efficacy of CNTs as drug delivery vehicles, CNTs can be coupled 
with targeting moieties providing selectivity to malignant cells while minimizing the toxic 
  19 
effect of therapeutic molecules on healthy tissue.  Selecting the targeting (antibody or non-
antibody) ligand is governed by the receptor expression, binding affinity and ligand density 
on the surface of CNTs. 
Several CNT systems have utilized monoclonal antibodies or antibody fragments as 
targeting ligands. Various studies explored different receptors in ligand-receptor targeting, 
such as tyrosine kinase-7 [159], biotin receptors [171], HER-2 [208] , B-lymphocyte 
antigen CD20 [209], carcinoembryonic antigen [210], p-glycoprotein [145], lipoprotein 
receptor [211], transferrin [198], epidermal growth factor receptor [152, 163], folate 
receptor [169, 212], Integrin αvβ3 [153], hyaluronate receptor [156], lectin receptors [213] 
and nuclear receptor [214]. Although targeting is considered a major advancement in the 
field, only a few receptors have been shown to be effective for targeting. Active targeting is 
a complex approach where various parameters play a role, such as the binding chemistry, 
the Spacer arm length and physiological factors such as protein binding.    
2.3.5 Thermal ablation by means of the intrinsic properties of CNTs 
In addition to conveying multiple therapeutic loads to selected tissue, CNTs offer a dual 
therapy opportunity compared to other multifunctional drug delivery systems. The 
confinement of carbon atoms in nanometer sized volumes enhances electromagnetic energy 
absorption, thereby generating heat [215]. That unique intrinsic property can be explained 
in terms of the electronic transition for the first or second Van Hove singularities that result 
in strong optical absorbance [45]. The movement of the Van Hove-like singularity in the 
density of states toward the top of the valence band augments the effective density of states 
near the Fermi energy and enhances the electron-phonon interaction, increasing the 
temperature of the nanotubes [216]. In addition, CNTs are ballistic in term of thermal 
conductivity [217].  
Both SWNTs and MWNTs have shown good promise as photothermal agents for 
hyperthermia. However, MWNTs have more advantages as they are activated by a broader 
band width of electromagnetic radiation, and more proficient in absorption of 
electromagnetic energy. The abolishing capacity of tubes is restricted to the cells present in 
the heating radial distance of the tube; therefore, MWNTs can offer better breach to cells 
[218]. The mode of cell death can be attuned to necrosis or apoptosis, dependent on the 
temperature chosen for ablation.  In case of apoptosis or heat-controlled necrosis, the 
thermal effect triggers the activation of heat shock proteins such as the Bcl-2 family 
proteins [219, 220]. Ghosh et al. [221] showed that encapsulating MWNTs with DNA 
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enhanced heat emission subject to the NIR irradiation. This also endorsed a 3 fold reduction 
of the original MWNT concentration required to escalate 10°C in suspension. 
In the advancement of ablation capacity, it is known that CNTs behave as classical dipole 
antennas, and the most efficient CNT agents are the tubes longer than half of the 
wavelength of the incident light [215]. In a study published by Torti and colleagues [218], 
they investigated the length effect of nitrogen doped MWNTs (N-MWNTs). They showed 
that N-MWNTs 700 nm and 1100 nm long showed significant cytotoxicity and cell death 
compared to 300 nm tubes when exposed to NIR. Moreover, the existence of structural 
defects in the carbon lattice caused by nitrogen dopant across the tube longitudinal axis 
showed an enhanced efficiency for cell destruction.  
Burke et al. [222] showed that at 100 µg dose of MWNTs injected intratumorally, there is 
efficient thermal ablation of kidney cancer both in vitro and in vivo. In addition to tumor 
regression after a single 30 second treatment at 3 W/cm
2
, they also report no tumor 
recurrence for ca. 3 months in 80% of the mouse population. Wang et al. [223] showed 
complete abolishment of glioblastoma xenografts targeted by antibody modified SWNTs 
before subcutaneous implantation. Zhou et al. [224, 225] showed that upon cellular uptake 
of PEGylated SWNTs, there was a localization in the mitochondria. The mitochondrial 
uptake is explained in terms of the existence of electric potential which is much higher for 
malignant cells compared to normal tissue. This was further interpolated as a selective 
mitochondrial destruction in cancerous cell after NIR stimulation. Levi et al. [215] showed 
that 10 seconds of exposure to NIR radiation leads to thermal ablation efficacy compared to 
those incubated with antineoplastic agents. Levi et al. also introduced an additional 
potential of NIR irradiation to act as an assisting therapy by enhancing cell permeability for 
treatment by chemotherapeutic agents afterward. 
In a noteworthy step in the development of state-of-the-art photothermal agents, Robinson 
et al. [226] administered PEGylated SWNTs (ca. 140 nm in length) i.v. in the tail of mice 
bearing 4T1 murine breast tumors. The tubes accumulated in the tumor site through the 
enhanced permeability effect in 3 days. Subsequent to the NIR irradiation, full tumor 
ablation was witnessed. No tumor reoccurrence was noticed for 6 months. The study also 
highlighted that SWNTs are much more efficient hyperthermia agents than Au nanorods. 
Another intriguing study by Antaris et al. [227] successfully administered isolated (6,5) 
SWNTs i.v.. They showed that SWNT constructs accumulated in 4T1 tumor xenografts, at 
a very low administered dose of ∼4 μg, and showed high thermal increase at the tumor site. 
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Similar studies investigated the surface modification chemistry of SWNTs to increase 
tumor accumulation and obtained similar results [228].  
Gannon et al. [229] reported hyperthermia induction by means of radiofrequency (RF) 
radiation. They studied the RF ablation effects of non-covalent functionalized SWNTs 
injected intratumorally in rabbits bearing hepatic VX2 tumors. The study demonstrated 
complete tumor necrosis 48 hours post injection. The treatment was selective, noninvasive 
and showed concentration-dependent thermal destruction. Although RF has better tissue 
penetration that NIR, the study highlighted that RF treatment causes damage to surrounding 
normal cells and incomplete thermal ablation of malignant cells.  
2.3.6 Photoacoustic abolition by means of the intrinsic properties of CNTs 
A unique approach was introduced by Kang et al. [230] employing the photoacoustic effect 
of SWNTs surpassing the RF and NIR thermal therapeutic efficiency. In comparison to 
photothermal therapy that uses long time continuous laser irradiation with a power density 
of 0.5-3 W/cm
2
, photoacoustic treatment requires only millisecond pulsed laser exposing 
the cells to 200 mW/cm
2
.  The rapid heat deposition and nonlinear thermal expansion 
generates a shock wave taking the shape of a bubble that causes the cell to explode [231, 
232]. It is worth mentioning that this cell burst will lead to the release of cell content to the 
surrounding tissue, and it might be engulfed by neighboring cells by phagocytosis, 
increasing tumor reoccurrence probability. 
The use of hyperthermia and photoacoustics to eradicate tumors is a thriving acknowledged 
application of CNTs in oncology. The transfer of such methodology to a clinical setting 
requires extensive exploration and optimization in irradiation parameters to provide 
localized heating by controlling the spatial and temporal distribution of heat [233-235]. It is 
also worth mentioning that the success of such treatment is not only dependent on the 
physiochemical characteristics of the CNTs but also upon the structural and chemical 
environment in the tumor and the delivery strategy to the tumor [236]. 
2.3.7 Carbon nanotube stealth strategies 
Following the administration of CNTs as therapeutic nano-carriers, various cells of the 
immune system are activated. The immune cells recognize foreign CNT constructs as 
pathogens that must be excreted or digested to more tolerable forms [237].  As a drug 
delivery device or therapeutic moiety, a sufficient time window must be secured to 
facilitate reaching the target site. The CNT smart systems need to be retained in the blood 
circulation, avoiding opsonins binding/tagging. For that, CNT stealth strategies have been 
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developed to limit the phagocytosis by the mononuclear phagocyte system and increasing 
the systemic circulation time from minutes to hours or even days [238]. As deliberated in 
earlier biodistribution context, all forms of engineered CNT constructs show high 
accumulation in the liver and spleen. To improve the bioavailability and to deceive the 
immune system, several stealth sheltering ligands such as polysaccharides and polyvinyl-
alcohol have been introduced.  
In drug delivery systems, polyethylene glycol (PEG) and PEG derivatives are known to be 
the golden standard imparting stealth characteristics [239]. In addition, PEG is nontoxic and 
FDA approved for human clinical use, which reduces the complexity when considering 
clinical transfer for such smart delivery systems.  PEG is comprised of a chemically inert 
polyether backbone with flanges of hydroxyl functional groups. The hydroxyl terminal can 
be altered to bind another functional group of interest or can be used directly for 
conjugation with other entities including imaging, targeting, therapeutic or further surface 
modification [238]. PEGylation of CNTs can be engrafted through chemical conjugation 
and, in the case of amphiphilic PEG derivatives, physical surface adsorption can be an 
alternative modification strategy. PEG endures spatial conformations inducing steric 
hindrance, preventing opsonization of the CNTs. This was explained as hydrogen bonding 
being established between the water molecules and the oxygen present in the PEG chains, 
forming a hydrated cloud that resists plasma protein interaction [239]. Jeon et al. [240, 241] 
showed through a mathematical model that long chain and high surface densities are 
desirable to induce steric repulsion upon the compression of  PEG layers induced  by the 
protein diffusion. The effect of van der Waals attraction between the hydrophobic surface 
of the nanoparticle and the plasma proteins was also studied and found to be negligible 
compared to the steric repulsion. Another motive for a thicker PEG layer is to overcome the 
van der Waals attraction, which is strong below 100 Å [242].Yamaoka and colleagues [243] 
demonstrated experimentally that the increase of PEG molecular weight from 6k to 190k 
increased the halftime of nanoparticles in circulation from 18 min to 24 hours. In addition 
to increased retention time, pharmacokinetic studies showed that PEG molecular weight is a 
vital parameter when the nano-constructs translocate from circulation to extravascular 
tissue. It is also important to mention that beside molecular weight, PEG structural 
conformations (branched or linear) play a dynamic role in effective stealth and avoiding 
undesirable binding.   
Yang et al. [244] reported that covalent attachment of SWNTs with PEG is much more 
effective than the physical adsorption of PEG derivatives of the same molecular weight as it 
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increases blood retention time (ca. 15 hours) and reduces hepatic uptake. Robinson et al. 
[245] investigated the use of a PEG derivative consisting of poly(maleic anhydride-alt-1-
octadecene) as a hydrophobic ligand for physical modification of SWNTs. His results 
showed an enormous increase in blood circulation time of the SWNT constructs - up to 30 
hours. Moreover, a lower hepatic uptake and tumor accumulation was noticed upon surface 
modification with the PEG derivative. 
2.3.7.1 Parameters affecting stealth 
Another consideration to be taken into account to obtain a high stealth efficiency is the 
physicochemical nature of the CNTs. Sund et al. [246] showed that SWNTs bind less 
cellular protein compared to spherical nanoparticles, detailing that the high radius of 
curvature of SWNTs is not thermodynamically favorable for binding plasma proteins. 
Several research groups have experimentally demonstrated that having an extremely high 
radius of curvature might lead to high impediment of uptake [247], and this was confirmed 
by defined mathematical models [248]. In addition, the agglomeration geometry or shape in 
terms of bundle diameter or size plays a role in how the CNT is recognized by the opsonins 
[249].   Shape effect on stealth is a more complex issue, because even though the tubes can 
be a target for plasma proteins they are yet not successfully phagocytosed. The shape 
governs the point of initial contact angle with the cellular membrane; an angle > 45
o
 will 
not initiate cellular uptake [249]. Shi et al. [250] demonstrated that cellular uptake of nano-
tubular structure arises from the tip contact point. 
CNT surface charge plays a vital role in escaping the innate immune system. In a recent 
study, Fleischer et al. [251] show that surface charge does not define the selection of 
adsorbed proteins, yet it primes the same protein to different binding status conformations 
on the nanoparticle surface. However, the different structural conformations influence the 
CNT stealth efficiency and the cellular uptake mechanism [138]. Another valuable factor to 
consider when designing stealth approach is the surface lipophilicity. The more 
hydrophobic the nature of the CNTs, the more they are vulnerable to plasma protein 
binding [252] which in turn affects the tissue distribution and excretion profile. The criteria 
for stealth design should be compromised to adapt the increased blood retention while still 
maintaining the hydrophobic nature to carry out drug loading or other required 
functionalities.  
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2.4 NANOTOXICOLOGY: TOXICITY ASSESSMENT OF CARBON 
NANOTUBES 
Nanotoxicology is the study of the adverse effects of nanomaterials on living organisms 
[253, 254]. Nanomaterials render a different toxicity profile compared to bulk material. 
With the prompt increase of CNT production for various nanotechnology applications, it 
became necessary to study how this class of fibers will interact with humans. Safety 
assessment of CNTs for nanotechnology and nanomedicine has gained a lot of attention 
[255, 256]. In studies of CNT toxicity, there are conflicting reports concerning exposure of 
CNTs to different cell lines. The inconsistency of these findings may be explained in terms 
of the intrinsic properties of the CNT itself. 
2.4.1 CNT Toxicity derived from physico-chemical characteristics 
2.4.1.1 Length & shape of CNTs 
Due to the morphological similarities with asbestos, the scientific community questioned if 
CNTs should own additional hazardous effects compared to compact shape nanoparticles 
[257-259].  The hypothesis was 
semi-acknowledged by the 
research conducted by Sato et 
al. [260], who revealed that 220 
nm long MWNTs injected 
subcutaneously showed slight 
inflammatory responses such as 
degeneration, necrosis, or 
neutrophil infiltration compared 
to 825 nm long MWNTs. A 
similar study by Poland et al. [261] showed that only long needle shapes of MWNTs (i.e. 
longer than about 15 μm) administered intraperitoneally showed similar mesothelial 
inflammogenicity to that of asbestos. However, they also showed that short and tangled 
MWNTs did not induce any pathogenic effect. Both studies [261, 262] pinpoint that long 
tubes might induce proinflammatory conditions due to the frustrated phagocytosis hindering 
CNT clearance. Yamashita et al. [262] highlighted that long MWNTs induce DNA damage 
compared to smaller ones. Other studies also reported that a long needle shape activates 
NLRP3 cascade secreting cytokine, i.e. IL-1R and IL-1β [263] 
Figure 4.  The role of carbon nanotube physical 
characterization in pathogenicity.  Reproduced from ref. [259] 
with permission from BioMed Central. 
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2.4.1.2 Agglomeration of CNTs 
The aggregation state of CNTs affects the shape and the surface area available for 
molecular interaction [264]. Belyanskaya and coworkers [265] investigated the influence of 
SWNTs with different degrees of agglomeration on primary cell cultures. They showed that 
large agglomerations decrease the DNA content in the cells compared to better dispersed 
SWNT bundles. Another interesting observation reported by Wick et al. [266] is that big 
agglomerations induced a higher pathogenic effect than asbestos fibers at the same 
concentrations in primary cell cultures. A similar observation was reported by Murray et al. 
[264] showing that collagen deposition and granulomatous lesions were linked to SWNT 
agglomerates while no granulomas were associated with exposure to asbestos. Moreover, 
SWNTs showed a signature of oxidative stress evidenced by accumulations of carbonylated 
and 4-HNE proteins [264]. Murray and colleagues [264] introduced a novel perspective of 
how CNT dose should be presented, showing that effective surface area along with mass 
dose is by far more important than specific surface area or particle number in influencing 
the toxicological responses.   
2.4.1.3 Number of CNT layers and layer rigidity 
The number of graphitic layers in the tube has been shown to play a prominent role in 
activating proinflammatory cascades and showing signs of necrosis, apoptosis or 
degeneration. Jia et al. [267] showed that SWNTs hindered phagocytosis of  alveolar 
macrophages at a low dose of 0.38 mg/cm
2
 compared to MWNTs that showed similar 
toxicity but at a higher dose of 3.06 mg/cm
2
. Muller and colleagues [268] demonstrated that 
MWNTs (˂ 1 µm in length) injected i.p. in Wistar rats displayed no carcinogenic response 
after 24 months.  
Nagai et al. [269] showed that highly crystalline thin MWNTs (ca. 50 nm in diameter) were 
more efficient in mesothelial piercing of cell membranes than highly crystalline thicker 
MWNTs (ca. 150 nm). More importantly, they report that mesothelioma was induced by a 
similar mechanism of asbestos, which is deletion of Cdkn2a/2b tumor suppressor genes.  
2.4.1.4 Catalytic impurities derived toxicity 
The inconsistency of available toxicity data can be elucidated in terms of the selected 
transient metal catalyst used during the manufacturing process. Metal catalyst containments 
such as Co, Mo, Fe, Ni  [270] are usually present in the nanomaterials even after applying 
rigorous purification techniques. The residual metal catalyst is usually protected by a 
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graphitic sheath or located in the tube channel [271]. Transient metal residues influence the 
toxicity and biocompatibility of CNTs.  
Pulskamp et al. [272] showed that there is a proportional relationship between the amount 
of metal contaminants and the toxicity profile. A higher metal residue leads to increased 
intracellular reactive oxygen species and reduced mitochondrial membrane potential. 
Kagan et al. [273] showed that metal contaminants alter the redox responses of 
macrophages. They showed that Fe-rich SWNTs lead to a significant reduction of 
intracellular glutathione and increased accumulation of lipid hydroperoxides in both PMA 
and zymosan stimulated RAW 264.7 macrophages. An interesting observation was noted 
by Guo et al. [274] , demonstrating that sample aging introduces a dramatic variation in Fe 
oxidation over the course of 1 year of atmospheric exposure due to progressive oxidation. 
2.5 BIODEGRADATION OF CARBON NANOTUBES 
Application of CNTs as a therapeutic nano-carrier was acknowledged with biodegradation 
findings. Allen et al. [275] reported the first study showing that SWNTs can be 
biodegraded through natural enzymatic catalysis. They showed that horseradish peroxidase 
is able to degrade oxSWNTs in the presence of low hydrogen peroxide concentrations (ca. 
40 µM) at static conditions. Horseradish peroxidase is a monomeric enzyme that contains a 
noncovalent bound ferriprotoporphyrin IX prosthetic heme group as an active site attached 
to the enzyme at the proximal histidine residue. The heme center is converted into a 
porphyrin π cation radical (Compound I) and an oxo-ferryl iron via a protein-assisted 
mechanism upon reaction with hydrogen peroxide [276].  Getting a deeper insight into how 
horseradish peroxidase degrades only oxSWNTs, Star and colleagues [277] reported a 
mechanistic study including molecular docking modelling. They raised several hypotheses 
on why p-SWNTs are not susceptible to enzymatic degradation which include 1) the 
intrinsic hydrophobic nature of the CNTs lead to aggregations and bundle formation that 
further leads to sedimentation and loss of suspension stability and thus no enzymatic 
interaction; 2) the presence of oxygen bearing negatively charged groups presented on the 
CNT surface enhances the interaction with enzymes through electrostatic interaction with 
positively charged residues. Through molecular modelling, they suggested that chemically 
oxidized SWNTs are oriented toward a positively charged arginine residue (Arg178) which 
acts as a binding stabilizer [277]. Molecular docking data showed that oxSWNTs are in 5Å 
distance to residues that are vital for catalysis of oxidation reaction, while p-SWNTs 
interact at the distal end of the enzyme placing it opposite from the heme moiety [275, 
277]. Russier et al. [278], showed that biodegradation increased with the introduction of 
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functional groups in a proportional approach. Horseradish peroxidase showed 100% 
degradation in at least 30 days of incubation [277, 278].  
Following the discovery that a plant enzyme is capable of degradation, Kagen et al. [279], 
investigated if similar human peroxidase is also proficient in CNT degradation.  They 
showed that human neutrophils and macrophage enzyme myeloperoxidase catalyze the 
biodegradation of SWNTs. Human myeloperoxidase generates strong reactive radical 
intermediates and hypochlorous acid in the presence of hydrogen peroxide. A complete 
absence of oxSWNT structure was reported after 24 hours of incubation with 
myeloperoxidase or sodium hypochlorite. The study systematically proves that a radical-
driven mechanism is the driving force of biodegradation. Myeloperoxidase is 
predominately expressed in granules of neutrophils and is released upon bacterium 
phagocytosis [280].  In vivo incubation of IgG-propped oxSWNTs with myeloperoxidase-
rich neutrophils demonstrated 100% degradation of oxidized SWNTs. p-SWNT 
degradation was also reported with myeloperoxidase enzyme, to a lesser extent [279].  
Moreover, they also proposed, through docking simulation, the bindings sites for both 
oxidized and pristine SWNTs [279]. It is worth mentioning that the modelling data of 
myeloperoxidase enzyme lacks relevant consideration with respect to the morphology of 
the oxSWNTs and the enzyme capacity to bind to such a big molecule. The reported model 
shows that the enzyme binds to the tip/cap of the oxSWNTs which is thermodynamically 
not favorable due to the formation of protein corona.  
In the case of finding more peroxide enzymes that play a role in SWNT degradation Andon 
et al. [281] showed that eosinophil peroxidase is also capable of degrading  oxSWNTs. In 
another in vitro setup, Neves et al. [282] reported that the RNA-coated oxidized MWNTs 
internalized by human prostate adenocarcinoma cells showed structural induced defects 
after 18 hours. However, the degradation mechanism was not discussed. 
Through an in vivo model, Shvedova et al. [283] provided direct evidence for the 
participation of myeloperoxidase in the biodegradation of oxSWNTs by using 
myeloperoxidase knockout mice. They showed that the degradation and clearance of 
SWNTs from the lungs of knockout mice subsequent to pharyngeal aspiration was 
significantly more robust than in wild-type mice.  In another interesting study, Nunes et al. 
[284] investigated the fate of amine-functionalized MWNTs stereo-tactically injected into 
the motor cortex of a murine brain. They noticed cellular transport to different types of 
brain cells including neurons that underwent severe structural deformation, yielding 
amorphous debris 2 days post injection. 
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The discovery of biodegradation of carbon based nanomaterial is indeed a remarkable 
milestone on the path to controlled and targeted spatiotemporal degradation of CNTs. 
Moreover, it opens up for the utilization of such a phenomenon to serve as a controlled 
therapeutic release mechanism. 
2.6 NANOPARTICLE-PROTEIN CORONA 
When nanoparticles as part of different formulations for biomedical applications come into 
contact with physiological media or blood, a spontaneous nanoparticle-protein interaction 
occurs. Blood serum is a complex body fluid that comprises more than 1500 proteins 
ranging in concentration over at least 9 orders of magnitude [285, 286]. The formation of 
protein corona is governed by the exposure time, the nature of the physiological 
environment and the physiochemical properties of the nanoparticle including size, surface 
charge, composition and surface functional groups [287, 288].  
 
Figure 5. Schematic of protein corona formation on a nanoparticle surface. Protein 
adsorption is a kinetic (k) and thermodynamic (K) function of both the individual 
proteins and NP properties, such as composition, diameter, and surface 
modification. Reproduced from ref. [251] with permission from American Chemical 
Society. 
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The initial interaction of nanoparticles is governed by the migration of the most abundant 
proteins that occur through concentration gradient or by potential energy gradient [289]. 
Spontaneous adsorption occurs if it is thermodynamically favorable. Proteins may undergo 
structural conformational change during adsorption to facilitate interaction with the 
nanoparticle surface [287, 290]. Alteration of protein structural conformation is irreversible, 
even after desorption from the nanoparticle surface [291]. Shang et al. [292] demonstrated 
that proteins adsorbed to highly curved nanoparticles tend to undergo fewer changes in 
conformation than those adsorbed to less curved surfaces.  
Biocorona is a complex phenomenon that is dynamic with time. Rapidly adsorbed proteins 
are exchanged with ones that have a higher affinity dominated by the Vroman effect [293]. 
The biomolecular corona is formed of two main strata, the hard corona and the soft corona. 
The hard corona is composed of tightly bound proteins that do not easily desorb, while the 
soft corona is composed of loosely bound proteins that adsorb with low affinity [294]. 
Walkey et al. [289] suggested that only the hard corona is due to the protein interaction 
directly with the surface of the nanoparticle, while the soft corona  is formed as a 
consequence of interaction with the hard corona.  
Shannahan et al. [295] examined the formation of protein corona on oxidized SWNTs, 
oxidized MWNTs and polyvinylpyrrolidone functionalized MWNTs, showing that all types 
were associated with a subset of proteins including apolipoproteins, titin, and albumin. 
Both oxidized types of CNTs are found to bind more proteins than polyvinylpyrrolidone 
functionalized MWNTs, demonstrating the importance of surface charge.  
Protein corona creates a new biological identity for the nanoparticles that define 
physiological response such as cellular uptake, circulation lifetime, accumulation, 
agglomeration, kinetics, and toxicity [296]. Hard corona plays an important role in the in 
vivo fate of nanoparticles. Furthermore, changes in the hard corona might occur when the 
particles are transferred to another biological compartment upon internalization [297]. Ge et 
al. [298] showed that π-π stacking interactions between the aromatic residues of the 
proteins and the SWNTs play a vital role in protein adsorption. Moreover, protein coated 
SWNTs alter their cellular interaction pathways and result in a much reduced cytotoxicity 
profile [298].  
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3 AIM OF THE STUDIES 
In 2008, the Food and Drug Administration and The Alliance for NanoHealth [299] declared 
a vision to facilitate the translation of leading nanomedicine into clinical use. In order to 
actualize a part of this vision, the present thesis aimed to assist the integration of single 
walled carbon nanotubes (SWNT) into the medical field. 
The main aim would be achieved via specific aims  
 To develope a novel imaging modality to facilitate real time imaging in order to study 
the  biodistribution of the SWNTs.  
 
 To investigate the effect of SWNTs on cytochrome P450 enzyme CYP3A4, using an 
in vitro model system of human CYP3A4 and human CYP reductase. 
 
 To study the degradation of oxidized and pristine SWNTs by CYP 3A4. In addition, 
to understand the role of SWNT surface chemistry in degradation.   
 
 To study the degradation of oxSWNTs by lactoperoxidase, a secreted peroxidase 
enzyme, and whether pulmonary surfactant hampers biodegradation. 
 
 To investigate the degradation of SWNTs coated or chemically functionalized with 
PEG and to assess their propensity to undergo biodegradation in vitro using 
recombinant myeloperoxidase (MPO) and ex vivo using primary human neutrophils. 
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4 MATERIALS AND METHODS 
Detailed description of the materials and technique utilized in the studies can be found in 
appended publications included in the thesis. The sections below provide a summary of the 
methods and their basic principles.  
 Oxidation and shortening of SWNTs 
In paper I, II, III, IV and V: p-SWNTs were dispersed using a tip probe sonicator (9 sec×6 
times) in a mixture of H2SO4 and HNO3 at a ratio of 3:1 respectively in a round bottom 
flask. The flask was then equipped with a condenser and the dispersion was refluxed. The 
resulting dispersion was then quenched by placing the flask in ice until the temperature 
decreased to 15˚C, then diluted by deionized water followed by filtration on a 100 nm pore 
size hydrophilic PTFE membrane disc. The filtrate was washed and not allowed to dry until 
it reached the pH of deionized water. The sample was then dried in vacuum at 80˚C 
overnight. The oxidized/carboxylated SWNTs (ox/c-SWNTs) were then suspended in PBS 
buffer pH 7.4 using bath sonication (Branson 2510) to obtain ox/c-SWNT suspension. The 
ox/c-SWNT suspension was ultra-centrifuged for 6 hours at 21000 g, the upper 70% was 
collected and another round of centrifugation was performed to ensure that any large 
bundles or impurities were removed from the solution. A calibration curve for the thus 
obtained ox/c-SWNT concentration was determined based on an absorption peak of 280 
nm, which is attributable to the surface π plasmon excitation due to the aromatic structure 
of the nanotubes [300].  
 Bioconjugation reactions to (ox/c-SWNTs) 
Chemical conjugation of biomolecules with ox/c-SWNTs was achieved using carbodiimide 
chemistry. Carbodiimides are one of the most important classes of compounds in organic 
chemistry [301]. They are widely used to mediate the attachments of biomarkers to 
polypeptides. Carbodiimide agents are used to activate carboxylic acids towards ester or 
amide formation. N-hydroxybenzotriazole or N-hydroxysuccinimide are often added to 
increase yields and decrease side reactions [302]. 
In paper I: EDC, a water-soluble carbodiimide was used in presence of N- 
hydroxysuccinimide to form an amide bond with the enzyme. Non-covalent binding was 
also completed via a physical adsorption process between the protein and SWNTs through 
π−π interactions, hydrophobic interactions and van der Waals force. 
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In papers II & V:  DCC, an organic soluble carbodiimide, was used to facilitate covalent 
conjugation of ox/c-SWNTs with methyl terminated linear PEG of different molecular 
weights. The organic solvent was extracted by rotary evaporator.  
4.1 PHYSICAL AND CHEMICAL CHARACTERIZATION METHODS 
In order to investigate the SWNT size and size distribution and morphology, electron 
microscopy was used.  
 Transmission electron microscopy (TEM) 
TEM is a microscopy technique in which a ray of electrons is transmitted thought an ultra-
thin sample. The images are formed due to the interaction of the electron beam with the 
specimen. The analysis was performed with a Joel JEM-2000EX at 200 KV. The specimen 
was prepared by dropping the suspension of SWNTs on a carbon coated 200 mesh copper 
grid followed by drying at ambient conditions.  
 Scanning electron microscopy (SEM)  
SEM is a microscopy technique in which an image of the specimen is formed by scanning it 
with a focused beam of electrons in two perpendicular directions covering a 
square/rectangular area of the sample. The analysis was preformed using GEMINI Zeiss 
ultra 55.  
 Fourier transform infrared spectroscopy (FTIR) 
The study of the surface chemistry of the particles was performed using FTIR analysis.  
The basic theory of FTIR is that most molecules absorb light in the infra-red region of the 
electromagnetic spectrum (0.8 μm to 1 mm wavelength) [303]. The SWNT constructs are 
irradiated with a broad spectrum of IR light and the absorbance frequencies are plotted. The 
FTIR spectrum is a fingerprint of a sample. The analysis was performed using Thermo 
Scientiﬁc Nicolet iS10 FT-IR Spectrometer. 
 
 Thermogravimetric analysis (TGA) 
TGA is a thermal analysis method which studies the change in weight of the materials 
against temperature variation in a controlled atmosphere. TGA analysis was completed using 
TGA Q500. 
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 Zeta potential measurements (ζ-potential) 
ζ-potential is a physical property that determines the colloidal stability. In suspension, the 
liquid layer surrounding the nanoparticle is constituted of two parts. The first inner layer 
referred to as the Stern layer is associated with the ions that are bound strongly to the solid 
surface of the nanoparticle. An outer layer formed of weakly bound ions constitutes the 
slipping plane. The potential at the slipping boundary is the ζ-potential. 
 Ultraviolet – visible spectroscopy (UV–Vis)  
UV-Vis absorption spectroscopy measures the attenuation of a beam of light after it passes 
through a sample. Ultraviolet and visible light are energetic enough to excite outer electrons 
of molecules containing non-bonding electrons or π-electrons to higher anti-bonding 
molecular orbitals [304]. UV-Vis is an informative method of empirically determining 
concentrations and of confirming successful conjugation or adsorption of molecules. 
LAMBDA 750 UV/Vis/NIR Spectrophotometer was used for this measurement. 
 Electrophoresis mobility shift assay (EMSA) 
EMSA is a very sensitive technique for the study of the binding properties of proteins 
[305]. In our work, we used it to confirm the binding of biomacromolecules to 
functionalized SWNTs. We also utilized the technique to study the different binding modes.  
 Bioluminescence measurements  
This is a robust method for determining the bioluminescence activity in a controlled 
temperature environment for a predetermined period of time. BioOrbit 1251 luminometer 
was used (collaboration with Biothema AB, Sweden). 
 In vivo imaging 
All animal experiments were conducted under the protocol approved by the Institutional 
Animal Care of Karolinska Institutet. Imaging was conducted on the IVIS™ system 
(Xenogen Corp., Alameda, CA) coupled to a data acquisition PC running Living Image™ 
software (Xenogen Corp.). During image acquisition, isoflurane anesthesia was maintained 
using a nose cone delivery system and animal body temperature was regulated using a 
digitally thermostated bed integrated within the IVIS system.  
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 High-performance liquid chromatography (HPLC) 
 HPLC is an analytical chemistry technique used to identify, separate and quantify chemical 
components in a mixture. The mixture is forced under high pressure in a column packed 
with functionalized particles. Interactions between the packing materials and the flowing 
solvent containing the chemical mixture lead to separation of the components. The 
separated components leave the column at different time points and are identified and 
quantified by means of attached detectors. There is a wide range of detector types including 
UV-Vis absorption spectrometer, Mass spectrometer, and fluorescence spectrometer [306]. 
The HPLC system used was Waters alliance.  
 Confocal Raman spectroscopy (CRS) 
CRS is spectroscopic technique that couples a standard optical microscope to a Raman 
spectrometer. CRS refers to the ability to spatially analyze the sample in lateral and depth 
coordinates. The spatial resolution is defined by the microscope objective selected, laser 
wavelength, and the laser quality. Typical spatial resolution is about 0.5-1 µm. The 
measurements were performed with a WITec alpha300 system in combination with a 785 
nm laser for excitation and a 100x objective. CRS was employed to determine the structural 
integrity and defects of CNTs in paper III, IV and V.  
 Atomic force microscope (AFM) 
AFM is a scanning probe microscope utilizing a probe to measure the physical properties 
such as sample surface roughness, morphology, sample length, width, and height. The 
vertical resolution is up to 0.1 nm and the lateral resolution is in the order of 30 nm [307].  
 X-ray photoelectron spectroscopy (XPS) 
XPS is a surface chemical spectroscopic technique. XPS can measure the chemical state, 
elemental composition, and electronic state of the elements within a material. In brief, the 
material is radiated by a beam of x-rays while simultaneously measuring the electrons and 
kinetic energy emitted from the top of the materials. Peaks appear in the photoelectron 
spectrum from atoms emitting electrons of a particular characteristic energy. These peaks 
enable quantification and identification of all surface elements (except hydrogen) [308]. 
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 Lactate dehydrogenase cytotoxicity assay (LDH) 
LDH is a biomarker for cytotoxicity. LDH assay is a colorimetric assay to quantify LDH 
release into media from damaged cells. It is the most reliable assay for nanomaterials. 
Wörle-Knirsch et al. [309] demonstrated that other cytotoxicity assays can yield misleading 
results due to the interference of nanomaterials with the detection dye.  
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5 RESULTS: SUMMARY OF THE MAJOR FINDINGS 
Paper I. THERMOSTABLE LUCIFERASE FOR IN VIVO IMAGING OF 
OXSWNTS  
*All figures reproduced with permission of the American Chemical Society. 
 
In this study, we introduced a novel method for visualizing the biodistribution of oxSWNTs 
loaded with a chemotherapeutic drug. The study showed that thermostable green 
fluorescent proteins (Luciferase from Luciola cruciate, LcL) can be a powerful method to 
determine the biodistribution subsequent to administration. Luciferase protein permitted 
imaging at a depth of a few centimeters which made it possible to visualize at an organ 
resolution.  
SWNTs were subjected to an oxidation treatment by means of an acid treatment 
(H2SO4+HNO3) which resulted in generation of oxygen bearing functional groups on the 
surface of SWNTs (oxSWNTs). The acid treatment also shortened the SWNTs. Material 
characterization was made by FTIR to confirm the presence of a carboxylic functional 
group. TEM imaging of oxSWNTs showed the pristine tubes were shortened and defects 
were introduced to the surface of the tubes.   
We investigated the mode of attachment on the LcL fluorescence intensity. Chemical 
binding of LcL to the oxSWNTs 
was validated by electrophoresis 
assay. We observed that the 
bioluminescence intensity is in the 
order LcL (control)> physically 
adsorbed LcL-CNT> chemical 
conjugated LcL-CNT (Figure 6). 
We assessed the effect of physical 
adsorption and chemical 
conjugation. oxSWNTs were first 
reacted with BSA protein to block 
possible conjugating sites or adsorbing sites on oxSWNT walls before adding LcL. The 
chemiluminescence intensity as shown in figure 7 was in the order of LcL+ BSA alone < 
LcL + physically adsorbed BSA-oxSWNTs = LcL + chemically conjugated BSA-
oxSWNTs. 
Figure 6*. Chemiluminescence intensity of LcL-CNT, 
chemically conjugated (empty circles), physically 
adsorbed (stars), and only LcL (filled circles).  
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The effect of physical adsorption and chemical conjugation of LcL to oxSWNTs on the 
bioluminescence decay rate and half-life was also studied. The plot of luminescence 
intensity expressed as ln(I) against time gives a linear relationship indicating a first order 
reaction. The bioluminescence of non-bound, chemically conjugated, and physically 
adsorbed LcL was investigated. In these three cases, the initial luminescence intensity was 
proportional to the LcL concentration and the bioluminescence decays following a first 
order reaction kinetics. No clear correlation between the LcL concentration or the coupling 
method and the decay kinetics was found.  
The LcL-CNTs conjugate biological 
activity after loading doxorubicin as 
a chemotherapeutic molecule was 
evaluated. We showed clearly that 
LcL remains in vivo biologically 
active. Distribution to liver, spleen, 
and inguinal lymph nodes was 
observed 20 min after i.v. 
administration of LcL-CNTs (figure 
8). 
Finally, we studied the biodistribution 
of LcL and chemically conjugated 
LcL-CNTs in FVB mice using IVIS 
spectrum at two different epochs 
subsequent to i.v. and intraperitoneal 
Figure 7*. Chemiluminescence intensity of LcL physically adsorbed to 
CNT, chemically conjugated BSA to SWNT, and a control experiment 
with only BSA.  
 
Figure 8*. Biodistribution of LcL-CNT-DOX (A) and LcL-
CNT (B) 20 min after IV administration. (A) Distribution 
of LcL-CNT DOX to the lymphoid, cecum, and mesenteric 
lymph nodes. (B) Distribution of LcL-CNT to spleen, liver, 
and inguinal lymph nodes. (C) In vitro chemiluminescence 
intensity of LcL-CNT and LcL-CNT- DOX. Well 2 and 4 
contain 10 and 5 μL of LcL-CNT-DOX, respectively, well 
6 contains 10 μL of LcL-CNT. ATP and D-luciferin were 
added to all wells. 
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(i.p.) administration. Imaging was performed at time t = 0 min, that is forthwith subsequent 
to the administration, and at time t = 180 min after administration. Following i.v. 
administration, it was evident that free LcL is swiftly taken up and distributed to the 
mucosal membrane of the mouth, the ventriculus, and the vulva mucosal membrane while 
the LcL conjugate is rapidly taken up and distributed to the liver, thymus, jejunum, and the 
vulva mucosal membrane. Three hours post i.v. injection LcL-oxSWNTs were redistributed 
to the jejunum site and to the vulva mucosal membrane. We also observed a strong 
bioluminescence from the subiliac lymph node within the left hind leg of the mouse. The 
uptake of LcL and LcL-CNTs was confirmed by imaging harvested organs obtained after 
sacrificing the mice. Subsequent to i.p. injection of LcL and LCL-oxSWNTs, the signal 
remained localized in the peritoneal cavity of the mouse even after 3 hours post injection as 
shown in figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9*. (a) The 8 min post i.v. administration of LcL only; (b) 180 min post i.v. 
administration of LcL only; (c) 8 min post i.v. administration of LcL-CNT; (d) 180 
min after i.v. administration of LcL-CNT; (e) 8 min post i.p. administration of LcL 
only; (f) 180 min after i.p. administration of LcL only; (g) 8 min post i.p. 
administration of LcL-CNT; and (h) 180 min after i.p. administration of LcL-CNT. 
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PAPER II. SINGLE-WALLED CARBON NANOTUBES INHIBIT THE 
CYTOCHROME P450 ENZYME -CYP3A4- 
In this study, we turned our attention to CYP3A4, the most prominent cytochrome P450 
isoenzyme in the liver. Using a combination of computational and experimental 
approaches, we investigated the interaction between oxSWNTs and CYP3A4 which is vital 
for progressing in vivo applications involving SWNTs. 
SWNTs synthesized by chemical vapor deposition were subjected to a chemical oxidation 
treatment that resulted in the generation of oxygen-containing functional groups on the 
surface of the SWCNTs. This yielded short oxSWNTs with a length distribution of (178.7 ± 
100 nm) and a zeta potential of -61.2 mV (Paper II & III). 
HPLC was used to quantify the conversion of testosterone to 6β-hydroxy testosterone, as an 
indicator of CYP3A4 activity. Our results demonstrated that there is a dose-dependent 
inhibition of CYP3A4 as shown in Figure 10a. We also validated this result under the 
present experimental conditions ruling out that inhibition can be a potential artifact due to 
SWNT physicochemical characteristics (Figure 10b).  
 
Figure 10. oxSWNTs dose-dependently inhibit CYP3A4. (a) The conversion of testosterone, to 6β-
hydroxy testosterone as a measurement of the enzymatic activity of CYP3A4. (b) The addition of 
oxSWNTs or oxSWNTs with a corona of bovine serum albumin (BSA) to the reaction mixture after 
completion of the enzymatic reaction demonstrated that c-SWCNTs do not interfere with the assay. 
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Figure 12. PEG-functionalization mitigates 
CYP3A4 inhibition.  The effect of different 
molecular weight (MW) polyethylene glycol 
(PEG) chains (750Da, 5kDa, 10kDa) on the 
oxSWNT-mediated inhibition of enzymatic activity 
of CYP3A4. 
 
Moreover, we investigated the potential role of the protein corona on the inhibition of 
CYP3A4 activity, by creating a synthetic protein corona with bovine serum albumin (BSA). 
We clearly demonstrated that the protein corona prevented the enzyme inhibition by the 
oxSWNTs (Figure 11). 
 
Figure 11. Mitigation of CYP3A4 inhibition by a protein corona. (a) The effect of bovine serum 
albumin (BSA) adsorbed onto oxSWNTs on the enzymatic activity of CYP3A4. (b) The protein 
corona effect is dependent upon the amount of BSA adsorbed onto the oxSWNTs. 
PEG is known as the gold standard surface modification to extend the circulation time in 
the blood stream. In this part of the 
studies, we examined the potential role 
of PEG functionalization and compared 
constructs with different grafting of 
linear PEG chains of various molecular 
weights (750 Da, 5 KDa, and 10 KDa). 
The results showed that there is a 
proportional relation between the molecular 
weight of the linear PEG chain mediating 
inhibition (Figure 12). 
Last, we tried to shed light on the inhibition 
mechanism employing molecular dynamics simulations and docking simulations. The 
analysis showed that CYP3A4 unfolding/misfolding is not the cause of enzymatic activity 
reduction. Moreover, we uncovered a novel finding, namely that oxSWNTs could 
potentially block the access channel to the active site of the enzyme. We showed that 
oxSWNTs adsorb onto the exit of the 2e channel of CYP3A4 through a complex binding 
mechanism, with hydrophobic, π−π stacking and van der Waals interactions playing a 
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dominant role, while the Coulomb and hydrogen bond interactions also promoted this 
interaction. 
PAPER III. DEGRADATION OF PRISTINE AND OXIDIZED SINGLE WALL 
CARBON NANOTUBES BY CYP 3A4  
In this investigation, we report for the first time the capacity of CYP450 (CYP3A4 
isozyme) to degrade pristine SWNTs (p-SWNTs) and oxSWNTs by means of the 
monooxygenase cycle in an in vitro setup. CYP3A4 was shown to be more proficient in 
degrading p-SWNTs than oxSWNTs. 
 
Figure 13. Raman spectroscopy was used for the analysis of oxSWNTs. (A), p-SWNTs (B), 
incubated with 30 pmol of CYP3A4, 7 µg of p-SWNTs or c-SWNTs, 40 µl of NADPH-generating 
system. The CYP3A4 content in the system was refurbished every 12 hours. Statistical analysis 
performed using one-way ANOVA followed by Tukey’s post hoc test. *P < 0.05 
We developed further insight on why CYP3A4 degrades p-SWNTs more proficiently than 
oxSWNTs by employing molecular dynamics and docking assessment. The analysis 
demonstrated clearly that p-SWNTs are packed more tightly into the CYP binding site, 
whereas the oxSWNT nanoparticle tends to protrude outside the binding cavity (figure 14).  
p-SWNTs were found to be bound strongly to the CYP enzyme with a minimal MolDock 
Score of −186.34 kcal/mol (ERY as reference control has MolDock Score = −141 
kcal/mol), while oxSWNTs have a weaker affinity to the CYP 3A4 receptor and a higher 
binding energy profile (MolDock Score = −111.47 kcal/mol). 
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Figure 14. Molecular docking 3D patterns of the p-SWNT (A) and oxSWNT (B) molecules docked to 
the CYP3A4 binding cavity. Molecular surface is reconstructed within 4.5 Å from the CNT atoms to 
visualize the carbon nanotube interaction with the CYP450 3A4 protein. 
We also investigated the potential of transfected HEK293 cell lines to degrade oxSWNTs. 
Raman analysis showed that there is no significant deterioration of oxSWNT structures 
after 96 hours of incubation. These findings raise more questions regarding the protein 
corona and how this can hamper cellular degradation. 
PAPER IV.  THE ROLE OF LACTOPEROXIDASE IN THE DEGRADATION OF 
SINGLE-WALLED CARBON NANOTUBES  
**All figures reproduced with permission from Elsevier. 
 
The degradation of oxSWNTs in the airways was discussed. In the present investigation we 
studied the role of lactoperoxidase (LPO), a secreted peroxidase present in the airways, and 
whether pulmonary surfactant affects the biodegradation of oxSWNTs.  
Pristine SWNTs with low metal content (4-8%) were subjected to chemical oxidation 
treatment to induce surface defects rich with oxygen bearing functional groups; oxygen 
content was quantified by means of XPS showing an increase of 3.1%. TEM imaging 
showed a length biodistribution of 1254 ± 479 nm while SEM images revealed the average 
diameter of the oxSWNT bundles to be 90 ± 42 nm. 
We assessed the biodegradation of oxSWNTs in an in vitro system using recombinant LPO 
supplemented with physiologically relevant concentrations of both cofactors SCN
-
 and 
H2O2. Degradation was assessed primarily by means of Raman spectroscopy. We found a 
significant time dependent degradation and the efficiency of degradation of ox-SWCNTs 
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was found to be bLPO + H2O2+NaSCN> bLPO+H2O2 > bLPO + NaSCN > bLPO (figure 
15). No degradation was observed for p-SWNTs in the presence of bLPO + H2O2+NaSCN. 
We also studied the effect of Curosurf, which is a natural surfactant derived from porcine 
lung, to analyze the possible impact that lung surfactant can have on the degradation 
competence of LPO. Raman analysis showed comparable time dependent structural 
integrity damage of Curosurf-coated oxSWNTs in the presence of bLPO + H2O2 + NaSCN 
as shown in figure 15. 
In order to assess whether biodegradation of oxSWNTs would occur in a more complex and 
physiologically more relevant medium, biodegradation of oxSWNTs was determined in 
cell-free bronchoalveolar lavage fluid (BALF). The magnitude of degradation shown by 
Raman analysis in the mBALF + H2O2 + NaSCN system was much lower when compared 
with the bLPO + H2O2 + NaSCN system as shown in figure 15.  
 
 
Figure 15**. Raman spectroscopy was used for the analysis of ox-SWCNTs incubated with bLPO + 
H2O2 + NaSCN in the presence or absence of pulmonary surfactant (Curosurf), or in the presence 
of cell-free murine bronchoalveolar lavage fluid (mBALF) with H2O2 + NaSCN. A time-dependent 
increase in the D:G ratio intensity was observed, and comparable results were obtained for ox-
SWCNT samples incubated in the presence or absence of Curosurf. Statistical analysis was 
performed using one-way ANOVA followed by Tukey’s post hoc test of 0 h vs. 24 h, 48 h, 72 h, 96 h 
and 120 h. *P < 0.05. 
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PAPER V. ENZYMATIC ‘STRIPPING’ AND DEGRADATION OF PEGYLATED 
CARBON NANOTUBES 
***All figures reproduced with permission of The Royal Society of Chemistry. 
 
PEGylation is known to be a gold standard for chemical modification of nanomaterials 
including SWNTs. In this study, we investigated the effect of PEGylation on the inhibition 
of SWNTs biodegradation in natural conditions. Furthermore, we examined the role of PEG 
chain molecular weight and type of modification [non-covalent PEG coating (cPEG-
SWNTs) vs. covalent PEG-functionalization (fPEG-SWNTs)] on the myeloperoxidase 
(MPO)-driven degradation of PEG-modified SWNTs (PEG-SWNTs). 
The oxSWNTs were functionalized with PEG by means of carbodiimide chemistry. The 
surface PEG densities for cPEG-SWNTs and fPEG-SWNTs were equal to ∼0.1 and 0.4 
mmol per gram of nanotube material, quantified by Kaiser test. AFM showed that the 
average height of cPEG-SWNTs and fPEG-SWNTs was ∼1 nm and ∼7 nm.  
Moreover, PEG-SWNT biodegradation in vitro with recombinant human MPO 
supplemented with H2O2 and NaCl in the presence of the metal chelator DTPA over a 
period of 7 days was investigated. Raman analysis (figure 16) showed that structural 
damage is induced to the sidewall of fPEG-SWNTs. More interestingly, MPO-driven 
degradation of fPEG-SWNTs decreased with PEG chain MW. fPEG-SWNT biodegradation 
was  also confirmed by measuring the intensity of the semiconductor S22 band at 999 nm 
wavelength in the UV-Vis-NIR absorption spectrum.  Both 2 kDa and 5 kDa fPEG-SWNTs 
showed a decrease of ca. 20% in the intensity of the S22 band. The degradation of 10 kDa 
fPEG-SWNTs was less evident. p-SWNT and cPEG-SWNTs did not undergo in vitro 
degradation. 
 
Figure 16***. Raman spectroscopy was used for the analysis of MPO-driven in 
vitro degradation of SWCNTs. p values * ≤ 0.05 by 2-tailed t-test 
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We investigated whether biodegradation of PEG-modified SWCNTs occurs in a natural 
system of ex vivo activated primary human neutrophils (Immune cells enclosing MPO). 
Neutrophils were activated by agonists fMLP and cytochalasin B to release intracellular 
MPO followed by addition of oxSWNTs, 2 kDa cPEG-SWNTs and 2, 5 and 10 kDa fPEG-
SWNTs. Raman analysis (figure 16) revealed a time-dependent increase in the D:G band 
intensity ratio for all the SWNTs, indicative of enzymatic degradation, with the exception 
of the p-SWNTs. 
 
Figure 17***. Raman spectroscopy was used for the analysis of ex vivo 
degradation of SWCNTs by primary human neutrophils. p values * ≤ 0.05, ** ≤ 
0.01, *** ≤ 0.001 by one-way ANOVA 
The finding that an ex vivo system of activated neutrophils is so much more efficient than 
the in vitro system based on recombinant MPO raised the question if other factors that 
human neutrophil azurophilic granules contain could play a role in that enhancement. We 
reasoned that assisting factors could remove some or all of the PEG chains on the surface of 
the SWNTs, thereby permitting the contact of peroxidase to the SWNTs.  Evaluating if 
neutrophil elastase (NE), a well-studied neutrophil protease, can be involved, it was evident 
that NE is able to remove ∼2.5% and ∼58% PEG chains from the surface of the 5 kDa 
fPEG-SWNTs following 6 hours and 6 days exposure as determined by TGA analysis. 
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6 DISCUSSION 
Nanomedicine promises a revolution in better health care, personalized medicine and health 
economics. The Food and Drug Administration (FDA) listed nanomedicine as a priority 
field in a 2006 report entitled “The Critical Path Opportunities List and Report”. With this 
fascinating field evolving, scientists and researchers exert joined efforts to unravel the full 
potential and create a working path for a fast and efficient bench-to-clinic translation. In 
2008, the FDA and the Alliance for Nano-Health identified 7 key hurdles that need to be 
addressed to facilitate the nanoengineered products [299]: 
1- Determination of the biodistribution of nanocarriers subsequent to systemic 
administration. 
2- Development of imaging modalities for visualizing the biodistribution over time. 
3- Understanding of nanoparticle transport across different boundaries ranging from cell 
membrane and different cell organelles to enzymatic boundaries. 
4- Developing reference bench marking nanoparticles. 
5- Developing mathematical models to predict risk and toxicological behaviors of 
nanoparticles. 
6- Developing computer models that predict the behavior of nanoparticles in a biological 
environment. 
7- Developing an analytical toolkit for nanopharmaceutical manufacturers.  
This thesis framework was designed to contribute in fulfilling some of the aforementioned 
challenges and to facilitate the transfer of CNTs from the bench to the clinical setting.  
Carbon-derived nanomaterials constitute one of the technologically most imperative classes 
of nanomaterials. CNTs have shown enormous potential for nanotechnology in general and 
nanomedicine in particular. Biodistribution of CNTs could be imaged by conjugation to a 
fluorescent molecule such as quantum dots (QDs) or fluorophores (FPs). QDs have a high 
quantum efficiency and high photo stability [310, 311] yet they have several drawbacks for 
imaging. For instance, QDs require an external excitation source. The technical challenges 
are difficult to overcome when imaging at non-superficial locations (typically larger than 1 
cm) within the tissue [312]. Also, the proclivity of the CNT-QD complex toward electron 
and/or energy transfer (Förster resonant energy transfer) from QD to CNT results in 
quenching the fluorescence response of QDs [313]. Furthermore, numerous QDs comprise 
cytotoxic ions such as Cd and Se even when they are encapsulated in a biocompatible shell; 
there is a considerable risk of ion release with time [314].  
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Tracing of CNTs can also be achieved by Radiotracers such as 
125
I ,
111
In, 
14
C , and 
86
Y 
[315]. Radionucleotides offer higher detection sensitivity and no limit for imaging depth, 
yet safety issues are of concern. They are also considerably more expensive than other 
imaging moieties [312]. Recently, bioluminescent proteins emerged as a promising imaging 
moiety posing a higher spatial resolution of 1 mm. Additionally, bioluminescent proteins 
permit imaging at a depth of few centimeters within biological tissue [312] which makes it 
possible to visualize at an organ resolution [316].  
Luciferase plasmids are commonly used as reporter genes in biological in vitro assays 
[317]. Scarce luciferase proteins are proper for in vivo imaging applications, because their 
biological tissue attenuates electromagnetic radiation signals over the “absorption” 
wavelength range. One of the most auspicious kinds of luciferase proteins is those which 
catalyze the oxidation of D-luciferin molecules via a two stage process in the presence of 
ATP. This process is accompanied by the emission of light over a range of wavelengths 
from 540 to 615 nm, which lies outside the absorption wavelength range of tissue [318]. A 
thermostable form of luciferase (LcL) made it possible to achieve a designed chemical 
construct (LcL+CNT) that remains sustainable long enough to image and investigate the 
biodistribution phase post injection and its accumulation in tissues/organs.  
The coupling of luciferase to SWNTs was reached by two different strategies. In the first 
system, LcL was conjugated to oxSWNTs via chemical bonding by means of carbodiimide 
chemistry. In the second system, LcL was attached to the oxSWNTs via a physical 
adsorption process by means of van der Waals force and π−π interactions.  The chemical 
conjugate was done through the primary amine groups present on the N-terminus of the 
polypeptide chain, or on the lysine side chain of the LcL. The existence of such functional 
groups on the outer surface of the protein structure offers readily accessible sites for 
chemical conjugation to oxSWNTs, minimizing major LcL-structure alteration that can lead 
to protein denaturation rendering a non-active protein.  
We observed a higher a higher fluorescence quenching for oxSWNTs chemically 
conjugated to LcL compared to oxSWNTs physically functionalized with LcL. A valid 
argument could be based in terms of energy transfer mechanism. LcL acts as an acceptor 
for photoexcited electrons from the oxSWNTs. Photoexcited electrons from the oxSWNT 
conduction band tunnel to the lowest unoccupied molecular orbitals of the LcL molecules, 
thus reducing the fluorescence intensity [319]. The fluorescence reduction in case of 
oxSWNTs with LcL physically adsorbed is expected due to the partial overlapping between 
the π-orbitals of the LcL and those of the oxSWNTs. 
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The observed bioluminescence intensity, in the order LcL (control) > physically adsorbed 
LcL-CNTs > chemically conjugated LcL-CNTs, can be explained in terms of the LcL 
protein structural change during the catalysis process. It is acknowledged that light 
emission during the oxidation of luciferin by LcL is initiated by proton abstraction at the 
carbon 4 position [320] plus large conformational change of the enzyme [321].The 
chemiluminescence intensity for the chemically conjugated complex was lowest because 
LcL is conjugated directly to the CNTs, which limits the conformational modifications. 
This is not the case in physical adsorption, where the protein has a higher degree of 
freedom for conformational changes on the CNT walls. These findings are in line with the 
findings of Tu et al. [322], who reported that chemical conjugation influences the 
conformational changes, such as the transformation of the original spherical shape to an 
elongated form. 
To further confirm that LcL chemiluminescence declination was due to the effect of 
chemical conjugation but not physical adsorption, a synthetic corona utilizing BSA protein 
was formed to block possible conjugating sites or adsorbing sites on oxSWNT walls. BSA 
was selected due to its isoelectric point, ca. 5.64, which is lower than that of LcL (6.4), 
offering a higher affinity to oxSWNTs. Moreover, BSA has 60 amino moieties in lysine 
residues facilitating its chemical conjugation. The insignificant enhancement of intensity 
for LcL + physically adsorbed BSA-CNTs and LcL + chemically conjugated BSA-CNTs 
might be attributed to the adsorption of oxy-luciferin either on the side walls and/or inside 
the oxSWNTs, precluding it from jamming the protein activity. 
Biodistribution in FVB mice of the chemical conjugate showed a different uptake pattern 
compared to free luciferase. The chemical construct was rapidly taken up and distributed to 
the thymus, the liver, the jejunum, and the vulva mucosal membrane. After three hours, 
LcL-CNTs were redistributed to the jejunum site and to the vulva mucosal membrane. 
Furthermore, we observed a strong bioluminescence from the subiliac lymph node within 
the left hind leg of the mouse. It is worth mentioning that nanoparticles (size <100 nm) 
have been reported to accumulate in the lymphoid organs [123]. This finding opens the 
frontier to questions of how the length of the CNTs can play an important role in affecting 
the biodistribution and in targeting the lymphoid system. 
In pursuing a multifunctional theranostic agent, we showed that loading doxorubicin (16% 
loading efficiency) did not hamper the activity of the LcL-CNT chemical construct. The 
biodistribution of the theranostic agent showed an uptake in the spleen, liver, and inguinal 
lymph nodes. It was evident that the liver had the highest accumulation of the oxSWNTs. It 
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is also quite acknowledged that the liver is the main accumulation site for many other 
nanoparticles. This leads to a question that has to be investigated: Do nanomaterials, 
namely CNTs, interfere with liver functions?  
 
Notably, the liver is a key organ involved in detoxification, metabolism, secretion of 
cytokines, and growth factor synthesis of proteins and lipids and immune/inflammatory 
responses. The cytochrome P450 (CYP450) enzyme family is a diverse group of proteins 
which are responsible for the initial biotransformation of xenobiotic compounds and drug 
metabolism. CYP450 plays a vital role in the determining the ultimate toxicological and 
pharmacological activity of 80% of available drugs. In addition, many substances 
(prodrugs) are bio-activated by CYPs to form their active compounds [323]. 
 
The impact of oxSWNTs on CYP450 function was evaluated using commercially available 
bactosomes, i.e., human hepatic cytochrome P450 isoenzymes (namely CYP3A4) 
coexpressed functionally in Escherichia coli with human NADPH-P450 reductase. E. coli-
expressed CYPs have been validated as surrogates to their counterparts in human liver 
microsomes [324]. CYP3A4 was chosen as it is the most prominent isozyme and 
responsible for more than 40% of drug biotransformation in drugs such as paclitaxel, 
doxorubicin, and docetaxel. CYP3A4 activity was determined utilizing the conversion of its 
substrate, testosterone, to its metabolite, 6β-hydroxy testosterone, by means of HPLC. 
HPLC evades the drawbacks of available fluorescence-based assays; it is acknowledged 
that carbon based nanomaterials interfere with dye based assays [309]. We revealed that 
oxSWNTs suppress the conversion of testosterone to 6β-hydroxy testosterone in a dose 
dependent manner. 
 
Xia et al. [325] anticipated and presented experimental evidence for the adsorption of small 
molecules, including steroid hormones, onto multi-walled CNTs. This observation led us to 
question whether the perceived inhibition of CYP3A4 conversion of testosterone to 6β-
hydroxy testosterone could be illuminated by adsorption of the parent compound or its 
metabolites. To rule out this possible artifact, we designed an experiment in which 
CYP3A4 activity was assessed with or without the addition of oxSWNTs to the solution 
after the enzymatic reaction ran to completion. We showed that the 6β-hydroxy testosterone 
concentration, determined by HPLC, was similar to that of the control (without oxSWNTs). 
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Validating that inhibition in an in vitro setup, we turned our attention to mimicking the 
physiological experimental conditions. In biological fluids, proteins adsorb to the surface of 
nanoparticles, which can critically alter the interaction of nanoparticles with biological 
entities [326]. Dutta et al. [327] identified albumin as the major plasma protein that adsorbs 
to SWNTs, demonstrating the influence of protein corona in influencing the molecular 
targeting and biological activity of nanomaterials.  We questioned if albumin protein corona 
would mediate CYP3A4 inhibition? The design of BSA corona would be reasonable due to 
the physiochemical nature of both SWNTs and albumin. BSA point of zero net charge is ca. 
5.64, giving a high affinity of BSA adsorption to the walls of oxSWNTs. Moreover, BSA 
had no counter action on the CYP3A4 enzymatic activity as the HPLC analysis revealed. 
Our results showed that a BSA corona was indeed successful in preventing the enzymatic 
inhibition caused by oxSWNTs.  The results also showed that protein corona has a positive 
potential and can be exploited to mediate toxicity profiles based on nanoparticle 
interactions.  
 
In recent years, many researchers have tried to design nanoparticles with chemical entities 
such as polyethylene glycol (PEG) to evade the corona formation in order to enhance 
circulation time, efficacy and site targeting. Our results have shown that PEGylated 
oxSWNTs can prevent the CYP3A4 inhibition and the enzymatic activity was proportional 
to the molecular weight of the PEG chains. PEGylation induces steric hindrance and 
repulsion between the oxSWNTs and the CYP3A4 bactosomes. These findings support the 
evidence that points to the inhibition being due to a direct interaction between CYP3A4 
isozyme and the oxSWNTs. In addition, it is in agreement with our AFM images showing 
the enzyme binding to the walls of oxSWNTs.  
 
To elucidate more of the potential inhibitory mechanisms, we employed computational and 
molecular dynamics simulations to understand the docking and further the interaction.  The 
CYP3A4 active site is positioned at the hydrophobic core of the protein. The proximity of 
the enzyme is linked to the surface of the enzyme through access channels. Enzyme gates 
prevent solvent access to specific regions of the protein and contribute to enzyme 
selectivity by controlling substrate access to the active site  [328].  Fishelovitch et al. [329] 
identified six distinct channels (2a, 2b, 2c, 2e, 3, and S). Through computing preferred 
channel path for substrate/product and their gating mechanism, we identified two specific 
channels (2e and 3) that best suit the departure of the 6β-hydroxy testosterone. To 
investigate the 2e egress conduit, we studied different model simulations altering the 
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orientation of oxSWNTs relative to the enzyme 2e gate. In all the models, oxSWNTs could 
effectively block the 2e channel via direct sidewall binding stabilized by hydrophobic and 
π−π stacking interactions. In addition, the analysis revealed that oxygen bearing groups do 
not integrate in the channel blocking it, yet the functional groups interact with the 
charged/polar groups. The data showed that the interaction of CYP3A4 with oxSWNTs is 
sustained primarily by the dispersive components of hydrogen bonding interactions and 
hydrophobic, π−π stacking. However, adsorption is driven in part by early electrostatic 
attraction. Despite the considerable number of contacts that are formed between the protein 
and the nanotube, the enzyme’s structure deforms only slightly.  
 
CYP3A4 catalyzes numerous reactions of endogenous and exogenous substrates by means 
of the monooxygenation cycle. CYP3A4 catalyzes a variety of reactions including aromatic 
hydroxylation [330], Baeyer–Villiger oxidation [331], epoxidation of C=C double bonds 
[332] and cleavage of C–C bonds ring formation [333]. From this perspective we 
questioned if CYP3A4 also can cause a chemical structural alteration to the walls of the 
pristine CNTs or oxSWNTs. The finding that CYP3A4 is proficient at digesting oxSWNTs 
and p-SWNTs by promoting the defect sites on the CNT structure was determined by 
Raman spectroscopy. Raman spectroscopy measures the relative ratio between the G and D 
bands. These bands are fingerprints for CNTs and represent the in plane vibration of the C-
C bond and the presence of disordered carbon, respectively [334]. These results support the 
fact that other families of enzymes operating by a different mechanism than peroxidase are 
capable of degradation of CNTs. It is known that some peroxidases exhibit homologous 
similarities up to 70% with CYP450; however, there are major chemical and structural 
alterations [335]. 
 
The fact that CYP3A4 degradation was observable for 5 days in both oxSWNTs and p-
SWNTs compared to 16 days in other reported studies based on peroxidase enzymes such 
as myeloperoxidase and eosinophil peroxidase can be illuminated in terms of the chemical 
nature of CYP3A4. All peroxidases have histidine as a proximal ligand to the heme iron, 
while in CYP450 the proximal ligand is cysteine thiolate [336]. The chemical nature of 
CYP allows a higher metal-oxo complex redox potential of 1.5-2 V compared to 1 V in 
peroxidase (for reference a robust hydroxyl radical is 2.3 V [337]). Moreover, in 
peroxidases the oxygen complex created by the catalytic turnover acts as an electron sink 
while in CYP450 the catalytic mechanism is orchestrated by two oxidation equivalents, in 
which electron transfer precedes the oxygen transfer [338].  Another parameter that might 
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assist CYP adequate degradation compared to peroxidases is the structural complexity. The 
CYP3A4 heme binding region and substrate oxidation site is defined by 4 α-helix forming a 
depression in the protein surface that allows a close approach to the redox partner to the 
heme group [339]. Contrary to the peroxidase enzymes, the structure is an irregular packing 
of α helices to form ellipsoids and no organized β sheet structure forming a frame over the 
heme pocket [337]. 
 
It was surprising to find that the p-SWNT degradation was more significant compared to 
oxSWNTs when incubated with the same reaction conditions in CYP degradation for 5 
days. By employing molecular dynamics and docking simulations, we were able to show 
that p-SWNTs bind strongly to the CYP3A4 enzyme compared to the oxSWNTs. p-
SWNTs bind to the enzyme primarily through hydrophobic interactions, permitting a larger 
surface area for interaction compared to ox-SWNTs.  
Our finding that degradation of ox-SWNTs was not successful in an in vivo setup utilizing 
transfected Hek293 cell line in Paper III can be explained in terms of protein corona 
formation. The cellular uptake was confirmed and eliminated the notion that ox-SWNTs did 
not come in close contact with the enzyme located endoplasmic reticulum. 
 
Many concerns have been raised regarding the adverse effect on human health and 
environmental safety in terms of the persistence/clearance and degradation of pristine CNTs 
and functionalized CNTs. Previous reports showed that both pristine and functionalized 
CNTs can prompt fibrosis and pulmonary inflammation as well as carcinogenic effects 
upon pharyngeal aspiration or inhalation [340, 341].  Through further exploration of the 
notion of protein corona influence on the degradation of CNTs, Tabi et al. [342] discovered 
that CNTs were present in bronchoalveolar lavage fluid  samples taken from the airways of 
64 asthmatic Parisian children. An earlier report by Murr et al. [343] reported the existence 
of CNTs, CNT aggregates and other  graphitic nanostructures created in the combustion of 
Texas piñon pine wood chips in air. Similar observations were also reported in India [344]. 
These findings support the fact that humans are routinely exposed to CNTs. How much 
CNTs infiltrate the lower respiratory tract is unknown. Pulmonary exposure to CNTs and 
other nanostructured carbons is neither avoidable nor controlled. 
 
Degradation of oxSWNTs by means of various human peroxidase enzymes including 
myeloperoxidase (MPO) and Eosinophil peroxidase upon activation of innate immune cells 
has been reported [281]. Lactoperoxidase (LPO) is known as the third largest peroxidase 
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family which is expressed and excreted by goblet cells present in the epithelial lining of the 
respiratory tract and other mucosal surfaces and exocrine secretions [345]. The LPO system 
is known as a major contributor to airway defenses against bacteria.  
Our findings show that LPO can proficiently break down the carbon back bone of 
oxSWNTs in the presence of the halogen substrates in an in vitro setup. To mimic 
physiological conditions, we also investigated the role of pulmonary surfactants and found 
that protein corona did not cause any interference with the LPO catalyzed-oxidization 
reaction nor with the degradation of oxSWNTs. Furthermore, we were able to show that the 
presence of biomolecules did not mask the assessment of degradation. These findings were 
contrary to the suggestions of Kagan et al. [279], showing that coating  SWNTs with 
phosphatidylcholine, a major phospholipid component of pulmonary surfactant, prevented 
MPO driven biodegradation. 
 
We complemented our findings showing that degradation occurs in murine BALF 
containing peroxidase activity combing both MPO and LPO. Although LPO and MPO were 
detected in lower concentrations compared to the in vitro setup, our data do not identify 
LPO (or MPO) as being solely responsible for oxSWNT degradation in mBALF. These 
findings are of importance in highlighting the possibility of oxSWNT clearance, yet they 
also shed light on possible implications that defense mechanisms against bacteria are 
compromised due to the preoccupation of LPO with oxSWNTs. These hypotheses are also 
in line with the findings of Shvedova et al. [346], showing that subsequent to oxSWNTs, 
bacteria exposure resulted in decreased bacterial clearance. This was found to be associated 
with decreased phagocytosis of bacteria by macrophages. 
 
It is evident that theranostic agents including CNTs are usually administered after being 
coated or functionalized with PEG as a stealth moiety, evading the reticuloendothelial 
system. We questioned if PEG availability and PEG binding mode on the outer side walls 
of the CNT can affect biodegradation. Using an established Myeloperoxidase (MPO) model 
for biodegradation of oxSWNTs, our findings concluded degradation of PEG (Mw: 2k and 
5k) covalently functionalized SWNTs (f-SWNTs). PEG molecular weight was proportional 
with the time needed to achieve noticeable degradation. This can be explained as being due 
to the fact that covalent bonding leads to an intense coverage of the surface of SWNTs, 
forming a mushroom brush transition conformation. The higher molecular weight of PEG 
induces steric repulsion upon the compression of the PEG layer caused by the protein 
diffusion [240, 241]. Moreover, a longer chain of PEG overcomes the van der Waals 
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attraction which is strong below 100 Å [242]. SWNTs bound to PEG by means of a non-
covalent bond (a-SWNTs) did not show any degradation behavior in the presence of MPO 
and needed biodegradation cofactors. It is worth stating that that the degree of MPO-driven 
degradation of f-SWNTs in our present study was relatively low when compared to the 
earlier study by Vlasova et al. [347]. This can be attributed to the fact that Vlasova and 
colleagues utilized a lower molecular weight of PEG (600 Da) and permitted only (10–
25%) grafting intensity.  
 
Questioning whether the enzymatic stripping of PEG and degradation of f-SWNTs is 
possible in an ex vivo setup, we found that f-SWNTs were not able to simulate MPO release 
when incubated with primary human neutrophils, proposing absence of endotoxin 
contamination. To facilitate the biodegradation study, primary human neutrophils were 
simulated by cytochalasin B to release MPO from the intracellular compartments. Addition 
of exogenous cofactors such as H2O2, compulsory to activate the peroxidase cycle, was not 
needed as f-SWNTs activate the NADPH oxidase.  Our results showed that both a-SWNTs 
and f-SWNTs were degraded proportionally with time with no clear dependence on either 
PEG molecular weight (2k, 5k, and 10k) or binding method.  Ex vivo degradation studies 
were only permitted for 8 hours as neutrophils show significant spontaneous cell death with 
time in cell culture [348]. Tracking the SWNTs by means of confocal microscopy showed 
that in 6 hours both a-SWNT and f-SWNT agglomerates were present outside the 
neutrophils, probably due to cell death or cellular exocytosis. This observation combined 
with the fact that the carbon back bone defect intensity increases in 8 hours suggests that 
degradation is taking place both intra- and extra-cellularly.  
 
All of these findings lead us to conclude that the presence of PEG does not hinder the 
digestion of SWNTs and also raises an important question as to how MPO evades the 
presence of PEG and physically attaches to the surface of SWNTs to start digesting the 
graphic structure.  We reasoned that other factors released from the neutrophils may play an 
intermediate role in cleaving the PEG chains from the surface of SWNTs.  Human 
neutrophil azurophilic granules enclose large amounts of three antibacterial serine 
proteases, cathepsin G, neutrophil elastase (NE), and proteinase [349]. We explored 
whether recombinant human NE can cleave the PEG from the surface in an in vitro setup. 
Our findings clearly showed that NE was successful in removing 2.5% of the PEG chains 
after 6 hours and 58% of the PEG chains after 6 days. With these findings we demonstrate 
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that the degradation in neutrophils is orchestrated by a combined action of MPO and other 
proteases released during degranulation.  
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7 CONCLUSION 
 
The present thesis contributes to the development of CNTs as a theranostic carrier by 
exploring the CNT biodistribution post systemic administration, developing biocompatible 
imaging modalities for visualization of CNTs, and most of all understanding the biological 
fate and interaction with different enzymatic boundaries. 
 
Paper I: 
 Thermostable Luciferase from Luciola cruciate is an effective imaging modality for 
CNT nanocarriers.  
 Loading doxorubicin as a chemo-therapeutic agent did not impair the 
chemiluminescent activity of Luciola cruciate Luciferase. 
 The liver has the highest share of accumulation of the LcL-CNT complex. 
Paper II:  
 We present a potential route of inhibition to the CYP3A4 enzyme by oxSWNTs as 
it blocks the access to the active sites. 
 Synthetic BSA Protein corona and PEGylation of oxSWNTs mitigated the 
inhibition of CP3A4. 
 These findings suggest that oxSWNTs may alter the metabolism of xenobiotic 
compounds by CYP450 enzymes in a clinical setting. 
Paper III:  
 CYP3A4 is proficient in degrading/metabolizing the p-SWNTs and to a lesser 
extent oxSWNTs. 
 A direct interaction between CNTs and CYP3A4 is required for the degradation to 
occur. 
Paper IV: 
 Lactoperoxidase (LPO) is capable of degrading oxSWNTs in an in vitro system.  
 Formation of bio-corona from porcine lung surfactant on oxSWNTs does not 
restrain LPO degradation capacity. 
 Cell-free biodegradation of oxSWNTs was also observed ex vivo in murine 
bronchoalveolar lavage fluid. 
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Paper V: 
 PEGylation of oxSWNTs may obstruct myeloperoxidase degradation capacity in an 
in vitro setup.  
 Using activated human neutrophils as ex vivo setup, oxSWNTs were degraded 
independently of PEG binding chemistry and PEG chain molecular weight. 
 Degradation is a complex phenomenon where striping of the PEG chain occurs by 
means of proteases followed by digestion of the graphitic backbone of oxSWNTs. 
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